SOUTH-SOUTH TRADE PROMOTION PROGRAMME
INDONESIA SUPPLY AND DEMAND SURVEY ON PHARMACEUTICALS AND NATURAL PRODUCTS
July 2005
Supply and demand survey on pharmaceuticals and natural products – Indonesia
The designations employed and the presentation of the material in this document do not imply the expression of any opinion whatsoever on the part of the International Trade Centre (ITC) concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. While every effort has been made to verify the information contained in this document, ITC cannot accept any responsibility for any errors that it may contain.
This report has not been formally edited by the International Trade Centre (ITC).
- ii -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Table of contents Page I.
INTRODUCTION
1
A. B. C.
1 5 5
Objectives and scope of the report Methodology Significance
II.
SUMMARY OF CONCLUSIONS AND RECOMMENDATIONS
III.
MAIN REPORT
10
A. B. C. D. E. F. G. H. I. J. K. L. M. N. O.
10 10 16 20 33 35 42 43 45 48 51 52 56 58 60
Industry overview Production capacity Market characteristics External trade Standards and technical regulations Trade and industry policy environment Export policies and incentives Import practices Distribution system Pharmaceutical sales promotion and pricing Maritime transport services Packaging Export credit and finance Trade promotion Conclusions and recommendations
6
REFERENCES
70
Annex: Company/Product profile forms
73
- iii -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
NOTES The following abbreviations are used: ACCSQ
ASEAN Consultative Committee for Standards and Quality
ACTD
Common Technical Dossier
ACTR
Agreement on Common Technical Requirements
APEC
Asia Pacific Economic Cooperation
ASEAN
Association of Southeast Asian Nations
ATL
Accelerated Tariff Liberalization
CEPT
Common Effective Preferential Tarriff
CIF
Cost, Insurance and Freight
EDL
Essential Drug List
FOB
Free on Board
GMP
Good Manufacturing Practices
ITC
International Trade Centre
MRA
Mutual Recognition Agreement
NEDL
National Essential Drug List
OTCs
Over-The-Counter Drugs
R&D
Research and Development
TRIPS
Agreement on Trade-Related Aspects of Intellectual Property Rights
VAT
Value Added Tax
WHO
World Health Organization
WTO
World Trade Organization
- iv -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
I. INTRODUCTION A. Objectives and scope of the report This report was prepared based on the terms of reference prepared by the International Trade Centre (ITC) initially in 2004 and subsequently updated to the current year 2005. The objectives of this survey are as follows: •
To outline the current market size and be able to project the future potential
•
To understand the complexities of the market structure and its characteristics viz. the distribution channels employed and their relative importance, layers of middlemen, etc.
•
To highlight the Import Policy and procedures, i.e. rules and regulations, duties, customs valuation, and practices, etc.
•
To identify the major impediments affecting imports, and suggest remedial action
•
To identify the major impediments affecting exports, and suggest remedial action
•
Indicating possibilities for augmenting supplies and new investment opportunities
•
Determining technical assistance requirements in the areas of product development, packaging, market promotion, joint export marketing, export financing, costing and pricing, training in export marketing, etc.
This report consists of nine parts and appendices. The first part of the report deals with the objective, methodology and sources of information and product description. The second part concerns with the domestic industry of pharmaceutical products and materials. The third part discusses the import aspect and the fourth part deals with export aspect. The fifth part of the report concerns with the market structure and volume as well as key players. The sixth part focuses on demand analysis including issue on health condition, health system, per capita consumption of pharmaceuticals and others. Part seven covers the distribution system of pharmaceuticals while Part 8 covers the government regulation related with investment, trading and import of pharmaceuticals. Following are the 21 categories of medicines (covering 128 groups) that are manufactured in Indonesia and a subject of this survey:
-1-
Supply and demand survey on pharmaceuticals and natural products – Indonesia
-2-
Supply and demand survey on pharmaceuticals and natural products – Indonesia
-3-
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Source: MIMS Indonesia
-4-
Supply and demand survey on pharmaceuticals and natural products – Indonesia
B. Methodology The survey has been based on findings from primary as well as secondary sources. Primary sources included one-to-one discussions conducted on-site in Jakarta by Mr Vicky Mukhi with members of Gabungan Perusahaan Farmasi Indonesia (Federation of Pharmaceutical Manufacturers), and other independent players in the Indonesian marketplace. Secondary data such as import and export statistics were collected from Central Bureau of Statistics, production figures were collected from the Ministry of Industry and Trade, the business associations, filed corporate annual reports, the Ministry of Health, World Health Organization, ADB and others. The data and information being collected were verified and crosschecked in order to obtain the most reliable data on the subjects of the study. The study has used a descriptive research as well as market intelligence approach in their implementation. The data were then processed, tabulated and analyzed to obtain the industry parameters and trends. The final report - as presented - was prepared by Mr. Vicky Mukhi, the consultant to the International Trade Centre.
C. Significance With a population of around 220 million people, Indonesia has been regarded as a huge potential market. The prospects of a big market have prompted domestic as well as many foreign investors to develop industries producing goods and services. The pharmaceutical industry represents one of these sectors. However, in Indonesia, as in other large developing countries, there has been a big gap between "potential" and its realization. This applies also to the pharmaceutical industry. Not all companies operating in Indonesia have profited from the increased consumption of pharmaceutical products. Many firms are beset with difficulties amid fierce competition; however, along with the economy, the pharmaceutical industry in general has grown.
-5-
Supply and demand survey on pharmaceuticals and natural products – Indonesia
II. SUMMARY OF CONCLUSIONS AND RECOMMENDATIONS The level of healthcare in Indonesia is poor and subject to considerable regional inequalities. Maternal health is a major problem, and infant mortality is high at 39 in every 1,000 births. Compared with other low-income countries, Indonesia has fallen behind in terms of investment in infrastructure and financial resources for health since the economic crisis of 1997-98. Demands on the system are increasing: demographic trends show an increasing number of people over 60 years of age, and growing migration to the cities. Average life expectancy has been rising, from 61.2 years in 1990 to 68.6 years in 2002, resulting in an increase in degenerative diseases. Private healthcare facilities are expected to expand The public sector’s ability to invest in healthcare provision is limited, owing to budgetary constraints. In 1998-99 Indonesia’s total health spending accounted for 1.6% of GDP, compared with an average of 4.5% of GDP in other low-income countries (World Bank data), and the government has therefore been actively promoting private healthcare provision, particularly at secondary and tertiary level. The increasing role of the private sector in healthcare raises questions about access, although private facilities are required to provide subsidized services to the poor.
Indonesia is coming under mounting international pressure to open its healthcare services to international competition. There is currently a policy of zero personnel growth in the public sector, and this will have negative effects on health service delivery. The country has recently implemented an essential drugs list, resulting in a considerable decline in the excessive use of antibiotics, multi-drug combinations and injections. State-owned companies are the main source of pharmaceuticals. Generic drugs are now produced by 4 government and 26 private companies. Essential drugs are subsidised in the public sector, and prices are controlled in the private sector. The drugs market has typically been growing by about 20% per year, but this is from a low base, and the market value in 2003 was estimated at US$ 3.7bn. -6-
Supply and demand survey on pharmaceuticals and natural products – Indonesia Annual consumption of drugs per head was estimated at US$ 4 in 2000, significantly below the US$ 11 recorded in Thailand and Malaysia. Use of public (and private) health services is low, but a WHO report found that it was not only the prices of services and drugs that accounted for the low level of use, but also travel time and cost as well as time lost from other productive activities. Medicines are expensive relative to average incomes. There is still a buoyant market in traditional medicines, which are cheaper and readily available. Overall, the huge currency devaluation and subsequent rise in drug prices has led to a sharp fall in demand, both for prescription drugs and for over-the-counter products. The pharmaceuticals sector is tightly controlled by the government In 2002 there were 198 pharmaceuticals manufacturers in Indonesia, including four state-owned and 35 foreign-invested companies. The government has repeatedly declared its intention to merge and then privatise the two largest state-owned pharmaceuticals companies, Kimia Farma and Indofarma, but weak market conditions have prevented the sales. In early 2003 the government announced that the sale of a 51% stake in Kimia Farma, which was included in the privatisation programme for 2003, would be delayed until 2004 because the company needed more time to restructure. In May 2003 two subsidiaries of Kimia Farma were created to operate in the retail and distribution sectors, and the company announced that it intended to focus on the production of generic medicines, which account for 53% of production at present. The merger of Kimia Farma and Indofarma is to take place after the two companies have completed restructuring. Having reported a large loss in 2002, in mid-June 2003 Indofarma forecasted falling sales in 2003 because of the government’s decision not to raise the prices of generic medicines, which account for 85% of Indofarma’s output. Local pharmaceuticals companies tend to be small-scale The majority of pharmaceuticals companies are small, manufacturing a limited range of products, and profitability is low; companies have been hit hard by the recent increases in utility prices. Foreignowned companies have threatened to relocate to cheaper locations such as Thailand following the utility price increases. Local manufacturers lack the financial resources to undertake research, and generally either produce drugs under licence from foreign drug companies or distribute generic drugs. The local pharmaceuticals industry is currently operating at 60-70% of capacity, as demand has suffered in the wake of the financial crisis. There is, however, growing demand overseas, and pharmaceuticals exports were over US$ 100 in 2003. The industry is heavily controlled by the government, which encourages the production and distribution of generic drugs. During the five years, from the start of the economic crisis in 1997 until 2001, 25 local pharmaceutical manufacturers went bankrupt, leaving more than 12,500 employees jobless. Strict competition due to a small market size, complicated import clearance and the slump of the Indonesian Rupiah against the US dollar, which until now has yet to be stable, are the bitter pills for the local industry to swallow. Most of the bankrupt companies have shifted their business to produce food supplements or medicinal herbs, which have less crowded markets. According to GP Farmasi (Indonesian Association of Pharmaceutical Companies), currently there were 198 pharmaceutical producers operating in the country from 223 in early 1997.
-7-
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Market size and characteristics The country's overall drug market size grows by around 20% every year, but the value is still small. The market value for 2002 was estimated to stand around Rp 15.2 trillion (US$ 1.5 billion). If compared to other South East Asian countries the Indonesian market value is the same as the Philippines and Thailand, around $ 1.5 billion. However, if compared to the average consumption of drugs per person, Indonesia is the lowest. With a population of 210 million the country's consumption of drugs only reached US$ 7.1 per person, while the Philippines was US$ 19.2 with its population of 78 million and Thailand US$ 23.8 with a population of 63 million. It is estimated that the market size grew only by 25% in 2002 or two percentage points below the 27% growth rate recorded in 2001. Around 70% of the market volume is controlled by 35 foreign manufacturers including the world's giants Pfizer, Roche, Aventis, Novartis and Mead Johnson and local pharmaceutical companies, especially small- and medium-sized operations, face immense competitive pressures. Local manufacturers are currently unable to compete with foreign companies due to the lack of investment and research resources for inventing new medicine. Local companies can only copy the foreign companies and sell at lower prices by buying the formula and changing the name of the drugs. To invent one new product, a multinational manufacturer can spend US$ 350 – US$ 400 million. The annual budget allocated for research can reach US$ 2.5 billion, which is higher than the Indonesian market value. Local manufactures are a bit lifted in sales by their ability to export the cheap, copied drugs to other poor or developing countries such as Myanmar, Vietnam, Laos, Cambodia in Asia, and Nigeria and Uganda in Africa. However, the value is still small, around US$80 million per year, and mostly nonprescription drugs. The country's five biggest pharmaceutical manufacturers in terms of market share were Kalbefarma, Sanbefarma, Dexamedika, Kimiafarma and Indofarma. The last two companies are owned by the state, and according to recent media releases (in the Jakarta Post, June 2004) there is serious consideration to merge the two i.e. Kimiafarma (stronger and profitable) and Indofarma (loss making generics producer) to reduce unnecessary competition between state-owned companies. Corrupt customs officials that make it difficult to legally import drugs as well as allowing many illegal drugs to flood the country after bribes are paid, and that has also seriously hurt the local industry. Around 95% of raw material for the industry is imported, which makes the timing of import clearance very important for a company to run efficiently and compete with others, foreign or domestic. Moreover, the local industry is also threatened by cheaper, smuggled and fake products which have continued to pour into the country since 1998, usually aided and abetted by paid off officials.
-8-
Supply and demand survey on pharmaceuticals and natural products – Indonesia
The dependency of the pharmaceutical industry on imported raw materials, has made it vulnerable to the fluctuation of country's currency against the US dollar, as was evident in the skyrocketing API (active pharmaceutical ingredient) prices during the economic crises that saw the Rupiah tumble against the US dollar. Such vulnerability leads to inflexible production costs and price of products. Pharmaceutical prices in Indonesia have increased by 200% since late 1997, far lower than the 500% increase in operating costs during the same period. Recommendations The new entrant to the Indonesian marketplace could initially choose to either export finished products through established channels, thereby minimizing resource commitments to the market. A scale up could then follow with either setting up a pharmaceutical plant fed through raw materials produced abroad (in a captive plant or procured from third party suppliers) or by establishing a basic ingredient plant that feeds the domestic industry and markets outside of Indonesia.
-9-
Supply and demand survey on pharmaceuticals and natural products – Indonesia
III. MAIN REPORT A. Industry overview The domestic pharmaceutical industry consists mostly formulation or assembling industry. There are only a few companies classified into fully manufacturing companies and less than 5 companies producing pharmaceutical basic materials. This situation is driven by the fact that expenditures on research and development of local pharmaceutical companies are very small i.e. around 1-2% of total sales as compared to some 15-16% of multinational companies. Machines or production facilities used are universal machines processing basic materials such as grinding machines, mixers and machines producing tablets, capsules, or other types of packaging or forms. In the production of medicines with single basic material such as generic medicines, a factory uses only simple equipment as the basic materials need no processing. Despite doubt that begins to haunt most of the country’s economic sectors in ability to compete in open market competition, the confidence is strong that the pharmaceutical industry will continue to grow and expand. The confidence was strong despite the fact that several years ago, the industry, which still heavily depends on import for basic materials, suffered a setback by the crisis with the sharp fall of the rupiah. Around 50% of 213 pharmaceutical companies grouped in the Federation of Pharmaceutical Companies (GPFI) were forced to slow down operation to 50% of their installed capacity because of the soaring prices of the imported basic material. The production fall was caused by the difficulties in basic material procurement with the soaring value of dollar against rupiah and slump on the domestic market with the weak purchasing power of the consumers. In addition, the costs of procuring packaging such as aluminum foil, plastic and bottle contributed to an increase in production cost for pharmaceutical products. The difficult condition rendered the industry a big blow especially Indonesian private companies. Foreign joint venture companies which total around 40 in number fared well despite the crisis as they have support from their principals abroad. The four state-owned companies also fared relatively better with the support from the government in basic material procurement.
B. Production capacity Pharmaceutical factories in Indonesia are "formulation" factories since most basic (active) ingredients are imported. So far the country has produced a limited quantity and few types of basic (active) ingredients. 1.
Geographical spread of pharmaceutical companies
GP Farmasi (Indonesian Association of Pharmaceutical Companies) members, to this point, only include firms with legal operating licenses, comprising 259 manufacturers and the following is a geographical spread of companies in the industry in Indonesia:
- 10 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Province
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
No. of factories
D.K.I. Jakarta 58 .............……................................. Java (West) 72 .................……................................ Banten 22 ...........................…...........................….. Java (Central) 31 ..................……........................…. D.I. Yogyakarta 5 .................….........................…. Java (East) 54 ........................…….......................... Bali 1 ......................................…...................……. D.I. Aceh ...............................……………………….. Sumatra (North) 10 .........................................……. Sumatra (West) 2 ..........................................……. Riau ........................................................………. Jambi 1 .....................................................……….. Sumatra (South) 3 ........................................…….. Bengkulu .....................................................….. Bandar Lampung ........................................……. Kalimantan (West) ......................................……. Kalimantan (Central) .....................................….. Kalimantan (South) ......................................….. Kalimantan (East) ........................................…… Sulawesi (North) & Gorontalo .........................…. Sulawesi (Central) .........................................…. Sulawesi (North-East) ....................................…. Sulawesi (South) .........................................…… - 11 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Maluku & Maluku (North) .................................. Nusa (North-West) 25 ...................................……… Nusa Tenggara (North-East) 26 ............................. 27 Irian Jaya ...................................................….. 24
Total .........................................................
259
Source: GP Farmasi (Indonesian Association of Pharmaceutical Companies)
2.
The economic crises and production changes
During the five years of the economic crisis (1997 – 2001) 25 local pharmaceutical manufacturers went bankrupt, leaving more than 12,500 employees jobless. Strict competition due to a small market size, complicated import clearance and the slump of the Indonesian Rupiah against the US dollar, which until now has yet to be stable, are the bitter pills for the local industry to swallow. Most of the bankrupt companies have shifted their business to produce food supplements or medicinal herbs, which have less crowded markets. Most of the surviving pharmaceutical manufacturers have facilities to produce at least 4 forms of medicines: tablet, syrup, cream and caplet. Some of them also have facilities to produce medicines in the form of drop, powder, granule, etc.
- 12 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
3.
Installed production capacity
The table below captures the installed production capacity of the Indonesian pharmaceutical industry.
Based on the ways of dispensing them, the medicines are classified into two groups: ethical, and nonethical medicines. Ethical medicines are those prescribed by doctors, while non-ethical medicines are those sold over the counter (OTC). 4.
Type of medicines produced
Pharmaceutical manufacturers usually produce both ethical and non-ethical medicines. PT Dankos Laboratories, for instance, produced 9 types of ethical medicines and one type of OTC medicines. Dankos produces two types of antituberculose medicines i.e. Rifampicin and Tibigon, 4 types of antibiotics i.e. Throcidan, Topcilin, Cefazol and Thianicol. A state owned company PT Indofarma produces some 11 ethical medicines with some 200 trade names. The company also produces OTC medicines including OBH cough syrups. The following table shows type of medicines of selected pharmaceutical companies in Indonesia.
- 13 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
- 14 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
- 15 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
5.
Cooperation with multinational companies
Many local manufacturing companies produce medicines under special production license from overseas manufacturers, particularly for ethical products. Of some 270 types of products produced by PT Kimia Farma, about 40 are produced under production license agreement with their overseas principals. Some of their principals are Heinrich Mack Nacht GmbH & Co. KG. A major private national company, PT Kalbe Farma, has also concluding production agreement with major multinational pharmaceutical companies including Bristol-myers Squibb, Warner lambert-Parke Davis, from USA, Fisons Pharmaceuticals plc dan Smith Kline Beecham plc of UK, Asta Pharma
C. Market characteristics 1.
Background
Indonesia is the fourth most populous country in the world: the population is estimated to be around 220 million, with an annual growth rate of 1.5% per annum. The population rate is likely to double by year 2040 giving a population of some 400 million people. Some 56% (or 120 million) of the population is aged under 25, while only 3.8% (or 7.5 million) are aged over 65, and 3.5 million babies are born annually, at a rate of 7 per minute. There have been some dramatic improvements over the last 30 years: life expectancy has risen from 42 to 62.7 years; infant mortality has declined from 140/1000 to 54/1000; and the crude death rate has halved from 14/1000 to 7/1000. Universal Child Immunisation (UCI) was achieved in 1992, but some preventable diseases such as polio, diphtheria and measles remain prevalent. Malaria has largely been controlled on Java, but not yet further afield; the prevalence of tuberculosis is some 2.4/1000; and Vitamin A deficiency has almost been eliminated. But problems remain. Degenerative diseases, such as Cancer and Cardiovascular disease which are the two greatest causes of death, are growing rapidly; Hepatitis B is carried by 60 million people; cataracts and iodine deficiency remain common, (70% of blindness is due to cataract) and AIDS is spreading rapidly. A lack of confidence in the domestic health system traditionally resulted in many people seeking medical services outside Indonesia, however this has reduced dramatically with the continuation of the economic crisis. Patients who may have previously sought overseas treatment are now being treated in private hospitals in Indonesia, and patients who may have previously been able to afford private treatment in a private hospital are now seeking treatment at the state run hospitals. Latest health figures state that there are 1,145 hospitals in Indonesia, providing a total sum of around 124,800 beds. But up to 600 new private hospitals are still needed. Recent legislation allows foreign medical personnel to practice in Indonesia, albeit on a restricted basis.
- 16 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
The economic crisis in 1997 had a major impact on the healthcare sector. But the provision of primary healthcare, as part of the social safety net programme, is still a priority for the Government of Indonesia focusing particularly on mother and child healthcare and nutrition. Government funds for new equipment and projects are still extremely scarce, although multilateral donor programmes do include healthcare projects and opportunities within these do exist. A market for refurbished medical equipment also exists. Preparations for the Government’s regional autonomy is in process and this includes the Ministry of Health. Decentralization will give responsibility to the local district level (of which there around 300 nation-wide) and this process for health provision is now completed. The total government expenditure for 2003 is Rp 253.7 trillion and the allocation for the healthcare sector is Rp 5.125 trillion (about 2% of total government expenditure). The aim is to improve the health status of the people by enhancing service coverage, quality and utilization of health facilities. The objective is to assist local governments, health professionals and communities in identifying health needs and priorities, developing locally appropriate solutions and improving health services quality. The project will comprise building and training activities, physical investments to improve service quality, and support for locally adapted health sector reforms. The Ministry of Health (DEPKES) is currently in the process of drafting new regulations to introduce a compulsory "National Health Insurance" scheme (JPKM) in the form of a managed care system. If this legislation is adopted it may be seen, in some quarters, as an additional Government Tax, and a further dispensation of responsibility by DEPKES. The national insurance premium is likely to be 6% for all employers regardless of whether they already have a medical scheme for their staff. There are more than 250 pharmaceutical companies in Indonesia. As a result of the economic crisis, there has been a rise in the popularity of generic medicine and a reduced demand for branded drugs. Approximately 90% of raw materials for pharmaceutical production are imported and therefore with the weakening of the Rupiah companies have been forced to raise their selling prices leading to a decrease in sales volume. These companies have experienced difficulties during the post economic crisis era due to the reduced demand for branded drugs, in addition to recent problems with official drug registration by the Ministry of Health’s Food and Drug Division. There are four state-owned pharmaceutical companies in Indonesia, all of which are currently in line to be merged into one SOE by the Government’s overall privatisation by 2004. These are PT Indofarma, PT Kimia Farma, PT Phapros and PT Bio Farme. The four companies are in the preliminary stage of synergising their businesses. In the longer term, the Government plans to sell shares in the single company that will result. Eventually opportunities are likely to be good in most areas of the health sector including hospital design and construction, hospital management, education and training and the supply of equipment. Suppliers are urged to maintain contacts within the market.
- 17 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
2.
Segmentation by type of product
In the 1998-2002 period, the market share of generic medicines grew by 41.3% annually on the average. The fast growth showed that demand for generic medicines has continued to increase especially amid the weak purchasing power of the people. The Drug and Food Control Agency (BPOM) has continued to increase supply of generic medicines as the government carries an obligation to meet the medicinal requirement of the people especially low-income people. The generic medicines are much cheaper than branded products and affordable by many people, because they don’t bear any promotion cost as well as research and development cost. For illustration, a generic cough medicine of Indofarma is only Rp 130 per tablet of 35 mg, while similar branded product can be as high as Rp 1,319 per tablet. Despite the fast growth, generic medicines have some 10% share of pharmaceutical market in the country in value. In quantity generic medicines exceed both OTC and ethical medicines. GP Farmasi has asked the government to allow the market to determine the prices of generic medicines with logo to attract the private sector to invest in generic medicines industry. Currently state-owned pharmaceutical companies control; 70% of procurement of generic medicines in the country. Among 80 private companies licensed to take part in the production of generic medicines only around 10% are active in producing generic medicines.
The competition is quite tight between pharmaceutical producers in the country both local and multinational companies. Therefore, producers resort to a number of strategies in order to survive. The most popular method is advertising through the mass media. The advertising cost is high and it is major element determining the price. Producers estimate that promotional campaigns account for 30% of the price of a pharmaceutical product. 3.
Consumption
The country's overall drug market size grows by around 20% every year, but the value is still small. This market value for 2002 was around Rp 15.2 trillion (US$ 1.5 billion). If compared to other South East Asian countries the Indonesian market value is the same as the Philippines and Thailand, around US$1.5 billion. - 18 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
However, if compared to the average consumption of drugs per person, Indonesia is the lowest. With a population of 210 million, Indonesia’s consumption of pharmaceutical drugs only reached was estimated at US$ 4 per capita. Compared to other ASEAN countries (e.g., the Philippines US$ 6 – population of 78 million, Thailand US$ 11 – population of 63 million, and Malaysia US$ 11), this figure is relatively small. The low consumption follows from the high prices of medicines relative to average incomes and consumers' weak purchasing power. Many people here prefer to use traditional medicines, which are cheaper and readily available. Sales volumes for prescription drugs dropped markedly when the economic crisis began in 1997 and have not yet fully recovered. Many Indonesians are now tending to rely only on self-medication as prices of prescription medicines and over-the-counter (OTC) products have also increased. 4.
Potential consumption
Prior to the economic downturn, the improved health and increased per capita income of Indonesians led to increased demands to provide better quality health care and health care products. Yet, increasing awareness could not, by itself, answer all public health problems. After the crisis hit the country, the situation changed dramatically. The hardships of 1998 today remain fresh in many people's minds. In that year the Rupiah fell nearly 80% from its level in 1997. Combined with an annual inflation rate of 10% at the end of 1998, the Rupiah's real depreciation then was one of the largest experienced by any nation in the post-war era. Some of the first inputs into public health to be affected by the 1998 depreciation were pharmaceuticals (including vaccines and contraceptives), of which an estimated 60 to 80% are imported. Limited surveys conducted by World Bank indicated that drug prices increased by 200 to 300% between November 1997 and March 1998. Many people here prefer to use traditional medicines, which are cheaper and readily available. Sales volumes for prescription drugs dropped markedly when the economic crisis began in 1997 and have not yet fully recovered. Many Indonesians are now tending to rely only on self-medication as prices of prescription medicines and over-the-counter (OTC) products have also increased. Nonetheless, the long run forecasts for the pharmaceutical industry in Indonesia are bullish and the GP Farmasi (Indonesian Association of Pharmaceutical Companies) projects a 10 – 15% growth per annum, which translates to an incremental monetary value of US$ 150 – 225 million per annum. 5.
Key players
Based on the sales figures of the last two years, a national private company, PT Kalbe Farma, enjoyed the highest sales in Indonesia. This company controlled some 17% of the pharmaceutical market, followed by PT Tempo Scan Pacific (12%) and PT Kimia Farma (10%). The following table presents key players in the local market for pharmaceutical and their estimated market share.
- 19 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
D. External Trade After a lengthy period of government policies promoting import substitution, companies have been able to meet all essential medical needs in Indonesia. Since the late 1980s, only a few products have needed to be imported. According to the Indonesia Association of Pharmaceutical Companies, there were 9,246 pharmaceutical products of different formulas being produced in the country, including 2,890 with generic names and 6,356 with trade names. 95% of basic (active) ingredients for Indonesia's pharmaceutical factories are imported. This is the case largely because the government (in a bid to reduce dependence on imports) has required foreign joint venture companies to produce at least one basic ingredient domestically. This regulation, however, could not be effectively enforced because only a few joint venture companies were able to comply with it. A producer of basic ingredients faces many problems. For one thing, producing pharmaceutical basic ingredients requires high technology and expensive research facilities. In addition, the principal companies abroad may not be anxious to transfer their technology to their Indonesian partners. However, investors have shown genuine interest in building factories to produce antibiotic basic ingredients in Indonesia. 1.
Imports by country of origin
Indonesia imports pharmaceutical materials from various countries particularly from Germany, United States, Switzerland, France, China and Japan. These countries contributed some 56% of total Indonesia’s imports of pharmaceutical products and materials. German is the biggest supplying country (14%) followed by United States and Switzerland. - 20 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia Beside, Japan and China, the main suppliers from Asian countries also include Singapore, Korea and India. Imports from India are quite stable at US$ 3-3.7 million a year or about 1.5% to total Indonesia’s imports of pharmaceutical material and products.
2.
Imports by volume
Imports account for roughly 95% of the basic ingredients needed for the country's pharmaceutical industry. By contrast, imports (legal) of pharmaceutical products account for only 2% of the total demand (see table below).
- 21 -
Import Value of Pharmaceutical Products (in ‘000 USD) 1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
75,746.77
78,368.00
35,922.00
51,380.00
78,144.00
57,515.00
45,050.00
34,226.00
33,340.00
50,327.00
38,266.00
58,569.00
55,510.00
Feb.
86,345.21
84,034.00
40,287.00
35,426.00
34,761.00
39,236.00
29,768.00
43,312.00
44,493.00
43,412.00
48,458.00
52,999.00
Mar.
91,564.49
108,639.00 44,942.00
48,947.00
46,772.00
46,288.00
57,484.00
39,288.00
48,496.00
50,792.00
39,573.00
65,893.00
Apr.
218,485.83
113,057.00 88,081.00
43,014.00
44,252.00
53,168.00
45,012.00
55,671.00
38,148.00
64,354.00
45,262.00
80,771.00
May.
79,196.62
83,278.00
44,789.00
40,202.00
52,480.00
51,549.00
41,313.00
50,813.00
48,939.00
54,520.00
48,411.00
55,912.00
Jun.
68,773.57
40,185.00
50,145.00
60,820.00
49,618.00
42,484.00
38,673.00
46,007.00
73,750.00
54,395.00
46,415.00
47,915.00
Jul.
72,056.08
22,961.00
38,200.00
51,127.00
42,052.00
56,743.00
59,157.00
47,662.00
65,934.00
41,454.00
61,487.00
58,053.00
Aug.
48,586.85
33,476.00
45,379.00
46,684.00
45,926.00
75,564.00
45,523.00
43,291.00
72,466.00
52,194.45
65,856.00
46,313.00
Sep.
64,250.17
41,322.00
34,859.00
39,000.00
40,182.00
63,933.00
40,179.00
44,721.00
71,670.00
40,281.51
58,786.00
51,095.00
Oct.
81,812.98
24,860.00
36,113.00
42,334.00
45,708.00
61,070.00
47,771.00
39,455.00
69,251.00
45,316.68
51,616.00
54,991.00
Nov.
57,387.36
48,003.00
41,223.00
40,048.00
64,052.00
48,494.00
39,645.00
47,191.00
54,679.00
47,265.94
52,687.00
38,734.00
Dec.
114,105.14
42,521.00
49,470.00
45,695.00
49,603.00
43,498.00
41,561.00
43,497.00
39,527.00
24,881.69
36,183.00
45,331.00
Total
1,058,311.07 720,704.00 549,410.00 544,677.00 593,550.00 639,542.00 531,136.00
Source: Bank Indonesia
535,134.00 660,693.00 569,194.27 593,000.00 656,576.00
Supply and demand survey on pharmaceuticals and natural products – Indonesia
- 22 -
1992 Jan.
Supply and demand survey on pharmaceuticals and natural products – Indonesia Imported products and basic ingredients can be divided into the following groups: antibiotics, hormones, glycoside and organo therapeutic gland antisera, provitamins and vitamins. Basic ingredients for drugs are imported from Germany, the U.S., Japan, the Netherlands, PR China, Italy, France, Australia and others. 3.
Raw materials
Type of materials consumed and volume of consumption Indonesia depends on imports for 85%-90% of its pharmaceutical basic materials. Manufacturing of medicines is dominated by foreign investment (PMA) companies. Local companies operate only as formulators assembling imported basic materials already processed. Imports of finished pharmaceutical products and basic materials could be estimated from the fact that the country depends on imports for 85%-90% of its pharmaceutical basic material requirement. The Central Bureau of Statistics (BPS) puts imported basic materials and finished products into two groups namely medicinal & pharmaceutical products and medicaments including veterinary medicinal. Based on data at the Pharma Materials Management Clubs (PMMC), the country’s imports of pharmaceutical basic materials were valued at Rp 2.14 trillion in 2001, up 8.9% to Rp 2.65 trillion in 2003. Therefore, in the 1999 - 2003 period, imports of pharmaceutical products tended to rise - from US$ 143 million in 1999 to US$ 331 million in 2003. The rupiah stability lately helped recover pharmaceutical industry from the lingering crisis. Imported finished products of medicines are mainly special kinds of medicines used little in the country. Imports are therefore small in value compared with imports of basic materials. Imported products of finished medicines are mainly ones not commercially feasible or profitable to be produced in the country such as anti cancer medicines and immuno-globulin.
4.
Imports of antibiotics basic materials
Antibiotics are one of the main pharmaceutical basic materials imported by the country. Based on a survey by Data Consult, three of 11 pharmaceutical companies surveyed are major importers of antibiotics namely PT Kalbe Farma, PT Combiphar, and PT Sanbe Farma. PT Kalbe Farma imports amoxycillin, PT Combiphar imports amoxycillin and ampicillin and PT Sanbe Farma imports ofloxacin, oxytetracycline base, rifampicin, roxythrimycin, and tetracycline HCL. - 23 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia Paracetamol, an active ingredient for analgesics is also imported in large quantity. Paracetamol dominates 85% of imports of analgesic basic materials. Paracetamol is imported mainly from China. The only company producing paracetamol, PT Riasima Abadi, which came on stream in 1982 could not meet domestic requirement. The company was almost idle through 1992 and 1993 because of failure in market competition. Earlier the company enjoyed protection with import restriction and tariff barriers. Now, however, the protection has been removed and the import duty has been reduced on that material. Among the 11 companies surveyed, two are main importers of paracetamol namely PT Bintang Toedjoe and PT Dankos Laboratories. The two companies also imports other analgesic basic materials namely acetosal.
- 24 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
- 25 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
5.
Sources of raw materials
Imports of pharmaceutical products and basic materials have been made from advanced nations such as France, Germany, Britain, Swiss, the United States, Japan, India, etc. as most of large pharmaceutical companies in the country are joint venture with foreign companies from those countries. Their principals abroad guarantee supplies of basic materials. Substantially large imports have also been made from China, and Singapore.
- 26 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
6.
Exports
Despite heavy dependence on imports for basic raw materials, Indonesia has exported pharmaceutical products for a long time. However due to stiff competition from countries like China (an active ingredient supplier to Indonesia), and India (with its prowess in generics), exports have been rather miniscule. Consequently, the BPS (Statistics Indonesia) and Bank Indonesia do not publish as detailed statistics on export of pharmaceuticals, and it is reflected as “Others” under the category of Industrial Exports. The adjoining table is an extract of data processed from figures published by the Pharmaceutical Products and Food Supervisory Board (B-POM), and other secondary sources.
Export Value of Pharmaceutical Products (in ‘000 USD) Year
Exports
1997
60390.00
1998
44400.00
1999
61030.00
2000
59870.00
2001
69920.00
2002
97980.00
2003
100000.00
Source: Various sources (processed)
An examination of the customs data indicates that Indonesia mainly exports quinine and its derivates as well as herbal medicines. Exports of quinine and its derivatives mainly go to Germany, U.S., Singapore, U.K., Vietnam, Spain, and Canada. Exports of herbal medicine go to Pakistan, Iran, and Hong Kong (the three largest markets for Indonesian herbal exports) and others including Bangladesh, Singapore, Malaysia, Libya, Taiwan, Yemen, the Netherlands, and Germany.
- 27 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Export Of Traditional Herbal Medicine Worth US$ 29 Million Amidst the economic crisis, the traditional herbal medicine industry has been able to boost production and increase exports, thanks to, amongst others, the readily available supply of basic materials from local sources and the use of sophisticated processing technologies. The traditional herbal medicine industry has managed to survive and grow and, even, diversify its export destinations. Another factor, which has contributed to the growth of the traditional herbal medicine industry, is the growing trend of "back to nature." The demand for traditional medicine, especially "fitofar," has continued to show significant growth over the last few years. Still another factor is the fact that Indonesia is rich in natural resources, which the traditional herbal medicine industry can take advantage of. Of the as many as 40,000 kinds of plants growing in Indonesia, only 1,000 kinds are already used as basic materials for medicine, including traditional herbal medicine. Source: Indonesian Commercial Newsletter; November 5, 2002
7.
Exports by type
As indicated by the following table, Indonesia’s export of pharmaceutical consists primarily OTC products. As many of local companies producing medicines under special license agreement with overseas principals, the local company has not freedom to export their products. The license usually defined for the local market territory. The company should obtain approval from their principal abroad to market their products outside Indonesia. It is not easy, since their foreign principals usually have their own subsidiary companies in the export destinations. In the meantime, it takes some times to register the export products in the country of destination. In the United States, exporters should acquire certificate from “ FDA Inspections”. Countries of destinations of Indonesia’s export include other ASEAN countries, Saudi Arabia, Hong Kong, Japan, Taiwan, Australia, Ukraine, Uzbekistan and others. One of notable export commodities is quinine. PT Kimia Farma is the only quinine producer. Export of Quinine was recorded at some 1,152 tons valued at US$ 483,5 thousand in 2002.
- 28 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
- 29 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
- 30 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
- 31 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
- 32 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
E. Standards and technical regulations The Indonesian National Drug Policy was established in 1983 with the objectives of ensuring availability of essential drugs through equitable distribution, ensuring drugs efficacy and safety, as well as promoting the rational use of drugs.
- 33 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
1.
Drug Regulatory Authority
At the central level, the regulatory authority for pharmaceuticals is the Directorate General of Drug and Food Control (DG DFC). Its main functions are to formulate policies and programs on drugs; to control production, distribution and utilization of drugs; and to supervise and control the supply of drugs for the public sector. In the private sector, DG DFC performs drugs registration, provides licenses for drugs imports and exports, controls drug promotion, monitors and supervises for implementation of Good Manufacturing Practices (GMP), assures the quality of drugs before and after in the market and monitors distribution of drugs. The Directorate General of Community Health Services coordinates with DG DFC to develop Standard Treatment Guidelines for primary health care. 2.
Selection
The Indonesia Essential Drug List (EDL) is revised every three years. The revisions are a result of meetings and consultations organized by the Committee for Essential Drugs List Formulation and Revision appointed by the Minister of Health. The Indonesia EDL is stratified to reflect requirements at different levels such as hospital, primary health center and village drug depots, while the WHO EDL is not stratified into different levels of health care. Compared to WHO EDL, the Indonesia EDL has fewer items. Public hospitals and community health centers are obliged to use drugs on National Essential Drug List (NEDL). Use of drugs outside of the NEDL is not allowed in community health centers but is allowed in hospitals. This deviation must be approved by the hospital director and reported to the National Committee on the NEDL. Due to budget limitation the total value of these deviations should not be more than 25% by value. The private sector is not obliged to follow the NEDL. However, some private hospitals have started using the NEDL as a reference for developing their own hospital formulary. 3.
Production and quality assurance
There are 287 registered pharmaceutical companies consisting of 40 multinational, 243 national and four government companies. In terms of value, 95% of all drugs for public and private sectors are produced locally. The national private pharmaceutical companies produce almost all drugs including vaccines on the NEDL. Drugs for the public sector and generic drugs are mainly produced by government-owned pharmaceutical companies. The National Quality Control Laboratory (QC Lab) and the 27 provincial QC Lab were developed with the assistance of WHO. The government controls for quality by taking samples from the field to be analyzed in the quality control laboratory. Implementation of Good Manufacturing Practices (GMP) in pharmaceutical factories was started in 1971.
- 34 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
F. Trade and industry policy environment 1.
Overview
In 1992, the ASEAN Economic Ministers formed the ASEAN Consultative Committee for Standards and Quality (ACCSQ), which set up a Pharmaceuticals Product Working Group (P-PWG) in 1999, with Malaysia as the lead country. The objective of this group of experts is to harmonise differences of regulations in the ASEAN member states, and to develop harmonised guidelines with the aim of arriving at a Mutual Recognition Agreement (MRA). The National Agency of Drug and Food Control (Jakarta, Indonesia) confirms that Indonesia observes patents for a period of 20 years, and is very keen to be regarded as a reliable partner in the World Trade Organization (WTO, the international organisation dealing with rules of trade between nations) and agreements like TRIPS (Agreement on Trade-Related Aspects of Intellectual Property Rights). 2.
Major agreements
(a)
TRIPS
Indonesia is of the view that TRIPS will delay the introduction of generics, increase prices and reduce access to medicines for the majority of patients in developing countries, TRIPS will on the other hand increase foreign direct investment as well as technology transfer, and enhance local innovation. In order to compensate the protection of innovative medicines, testing and regulatory approval of generics will be allowed before patent expires. Also parallel importation without the consent of the patent holder, and Compulsory License (marketing authorisation granted without permission of the patent holder) is allowed in defined cases. (b)
ASEAN Mutual Recognition Agreements
AFTA aims to eliminate all tariff rates, non-tariff barriers and technical barriers to trade. In order to reach this challenging goal, product standards need to be harmonised through alignment with existing international standards e.g. ICH, and by implementing Mutual Recognition Agreements (MRAs). The Bureau of Trade, Industry and Services, ASEAN Secretariat, Jakarta, outlines that MRAs help to avoid duplication of testing, reduce costs for industry and encourage innovation. In 2000, the ACCSQ signed a Memorandum of Consultation with the USA. There is also an EU Regional Cooperation Programme on Standards, Quality, and Conformity Assessment to be implemented in the ASEAN region. For the pharmaceutical industry, however, the most important ASEAN MRA is the Agreement on Common Technical Requirements (ACTR) and subsequently on a Common Technical Dossier (ACTD) in this region. The plan is to agree on the ASEAN CTR first, followed by an agreement on the ASEAN CTD.
- 35 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
(c)
ASEAN Common Technical Requirements (ACTR)
In a first phase, the experts compared existing registration requirements, and developed the ASEAN Common Technical Requirements (ACTR). The workload was split between the countries as follows: •
ACTR – Administrative Data: Malaysia
•
ACTR – Quality: Indonesia
•
ACTR – Safety: The Philippines
•
ACTR – Efficacy: Thailand
3.
Customs procedures in general
(a)
Structure of the tariff schedule
Indonesia applies a nine-digit tariff nomenclature based on the Harmonized System. The tariff schedule has six columns showing the import duty rates as well as the rates of additional import duties, value added tax, sales tax on luxury goods, and import trade procedure regulations. The last column is reserved to accommodate other provisions, which are not yet accommodated in the previous column. (i)
Tariff rates
Import are classified in four broad groups for tariff assessment purposes, with the highest duties applying to the least essential items: Group A for most essential items such as, rice, flour, certain iron and steel products, certain organic chemicals and pharmaceuticals, cotton, medicine, some fertilizers and insecticides, agricultural and industrial machinery and equipment, and some raw materials. Group B includes essential items, i.e. materials and spare parts for industry. Group C for less essential items, and Group D covers luxury goods, some consumer goods; and in the case of manufactured goods and machinery, finished goods and those that lessen the need for manpower are subject to higher rates of duty. In general, tariffs are high on goods less essential for economic development and basic consumer needs and goods competing with locally produced items. (ii)
MFN
MFN duty rates range from 5% to 30% based on the CIF value. All food items are dutiable at a maximum of 5%. Motor vehicles are dutiable at up to 80%, with automotive parts dutiable at 15%. Distilled spirits and certain basic chemicals are dutiable at 170%. In the agricultural sector, some products such as wheat, rice flour, yellow soybeans, cane sugar, coconut and palm oil are zero-rated.
- 36 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
(iii)
Bound rates
Bound rates are set on about 38.4% on all goods, 47.3% on agricultural goods, and 36.8% on manufacturing goods. (iv)
Temporary reduced duties
Duty reductions and suspensions are granted to investment import destined to selected internal market oriented industries and certain service activities. Goods imported for use in the manufacture of export products are exempt from import duties, value-added taxes, and sales taxes, as are goods imported for use in foreign-funded government projects. The main exemptions or reductions cover the importation of capital goods and raw materials used in the production processes of projects approved by BKPM. There are also schemes of drawback and exemption, which provide for the importation of inputs free of tariffs and licensing requirements. Also, the Finance Ministry may grant additional tariff exemptions to promote certain industries, e.g. certain cable makers and producers of electronic products for imports of polyethylene. On January 2001, the government has decided to reduce import tariffs between zero and 25 % on over 1,000 product items. The import tariff reduction affects a wide range of products including paint, varnish, cosmetics, woven cotton clothes, gold (not coin), platinum, cooking wares, screws, gloves, bed covers, toys, synthetic flowers, watches, electrical devices and many other products. (v)
Preferential duties under trade agreements
As the vast majority of Indonesia imports are subject to MFN rates, Indonesia tariff preferences are essentially confined to ASEAN partners. Duty rates under the Common Effective Preferential Tariff (CEPT) scheme are only valid for imported goods bearing certificates of origin from ASEAN countries except goods valued under US$ 200 FOB. The preferences relate to the implementation of the AFTA scheme, since the vast majority of Indonesian imports are subject to MFN rates. Indonesia is a member of the Association of Southeast Asian Nations (ASEAN) together with Brunei, Cambodia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam. ASEAN aimed at promoting economic, social, cultural and scientific ties, as well as trade and monetary policies. Other areas of cooperation among ASEAN members include harmonization of standards, reciprocal recognition of tests and certification of products. In 1992, ASEAN members called for the formation of an ASEAN Free Trade Area. In December 1998 members agreed to implement the AFTA by 1 of January 2002. In this regard, the six original founding members of ASEAN, Brunei Darussalam, Indonesia, Malaysia, Philippines, Singapore, and Thailand, would advance the implementation of AFTA from 2003 to 2002. In addition, a minimum of 85% of the tariff lines in the Inclusion List of these nations would be reduced to 0-5% by 2000 and 90% by 2001. Vietnam which joined ASEAN in 1995 would implement its tariff reductions to 0-5% by 2003; Laos and Myanmar which joined the group in 1997, will complete the reductions by 2005. Cambodia joined ASEAN in 1999 and will complete the tariff reductions by 2010. No common external tariff is planned; tariff rates on imports from non-Asean countries will continue to be determined individually. - 37 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Consequently, since 1 of January 2003, the ASEAN countries have announced the abolishment of tariffs on 60 % of traded goods and the introduction of a 5% on import tariffs within its six original members, i.e. Indonesia, Brunei, Malaysia, the Philippines, Singapore and Thailand. Products affected essentially by this measure are electronic products, machinery items and petrochemicals. And good excluded from the tariff-reduction agreement are goods of key industries in some of the member countries; for example, Indonesia and the Philippines will delay the 5% cap on sugar and petroleum, and Malaysia will shelve the cap on car imports, until 2005. As for Cambodia, Myanmar, Lao People's Democratic Republic and Vietnam, the four ASEAN's latecomers, will introduce the 5 % tariff cap only in 2010. Indonesia is also a member of the Asia Pacific Economic Cooperation (APEC) along with Australia, Brunei, Canada, Chile, China, Chinese Taipei, Hong Kong, Japan, Rep. of Korea, Malaysia, Mexico, New Zealand, Papua New Guinea, Peru, the Philippines, Russia, Singapore, Thailand, the United States, and Vietnam. APEC is a multilateral forum formed in 1989 so that Asian and Pacific economies can promote economic cooperation and mutual assistance in developing key economic sectors, including trade and investment. On 15 of November 1994, member countries agreed to implement open and free trade among themselves by 2020, with advanced industrialized nations realizing the trade liberalization goal by 2010. At their 1997 meeting in Vancouver, APEC leaders agreed on Voluntary Sectoral Liberalization (EVSL) to take place in 15 sectors and the tariff elements of nine sectors were identified under the accelerated tariff liberalization (ATL) package i.e. chemicals, energy, environment, fish and fish products, forest products, gems and jewellery, medical equipment and instruments, and toys, as well as a mutual recognition agreement concerning telecommunications. The ATL initiative aimed to achieve a zero target for almost all the sectors by 2005. (b)
Fees (Customs Duties and Tariff Nomenclature)
Customs duties and import-related taxes currently applicable are: •
Import duties which vary from 0% to 170% rates;
•
Value Added Tax (VAT) which is 10% except for certain goods (e.g. unprocessed and/or natural products);
•
Sales Tax On Luxury Goods with rates vary from 10% - 75%;
•
Income Tax, which is 2.5% for Registered Importers and 7.5% for Unregistered Importers;
•
Anti-dumping and countervailing duties, if any.
The above taxes are on CIF (Cost, Insurance and Freight) basis. Payment of the taxes can be done through foreign exchange bank or directly through Customs Office during office hours before submission of customs declaration. At Customs Offices where EDI system is fully implemented, payment can be done through electronic transfer.
- 38 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
(c)
Valuation
The customs value of imported goods is the transaction value which is the price actually paid or payable for the goods and may be adjusted in accordance with the provisions of article VIII of the agreement on Implementation of Article VII GATT 1994 (WTO Valuation Agreement). The Indonesian Customs has implemented the agreement fully since 1 January 2000. The Agreement provides that transaction value between both the buyer and seller can be accepted as long as both sides are not related, or where the buyer and seller are related, that the transaction value is acceptable as long as it does not influence the price. Several basic principals used by the customs to determine whether or not the relationship influence the prices are as follows: •
Where the price paid is based on normal transaction in trade of the industry;
•
The import price is relatively the same as the selling price to the unrelated party; or
•
The import price has already included production cost and profit.
(d)
Inspection
Indonesian Customs has been using EDI (Electronic Data Processing) to process customs declarations submitted by the importers. The system is done especially in major ports such as Tanjung Priok Seaports and Soekarno-Hatta Airport branch offices. In other offices, it may be done manually or using diskettes (semi-computerized). Customs examinations, consisting of document verification and/or physical inspection, are applied for imported goods based on very selective basis. Physical inspections shall be focused particularly on high-risk imported goods. High-risk means that physical inspection shall be applied only based on customs intelligence information or by random sampling automatically determined by computer. The imported goods that should be physically examined are passed through red channel which are not more than 10% of total import, while the others are passed through green channel. Indonesian Customs has set up a standard time frame for each step of cargo clearance. For example, red channel or green channel decisions must be done within 4 hours since the import declaration was submitted, and when the physical examination is needed, it must be ready to be conducted within 12 hours and finished not more than 40 hours. Also, when there is no indication of cheating, the cargo can be released before the document clearance for importer’s own good. Any person/importer who is not satisfied with the decision made by the Customs regarding tariff classification and/or valuation, may file a written objection to the Director General of Customs and Excise within 30 days of the date of the assessment by depositing a security promise at the amount of the taxes due. The Director General should make the decision on the objection within 60 days period. If the period has passed without any decision made, the objection shall be deemed accepted and the security must be returned. If the person/importer is still unsatisfied with the decision made by the Director General regarding classification and valuation, he or she still has the chance to file written appeal to the Board of Tax Dispute Settlement within 60 days after the taxes due have been paid.
- 39 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
(e)
Activities/measures
The Indonesian Customs Authority has taken all necessary steps to better facilitate export and import. It also has been working diligently to transform itself from merely an agent of revenue collection and law enforcement to amore trade facilitator. To meet this challenge, some measures have been taken to improve customs services. These include: •
In April 1, 1995, Indonesia enacted a new Customs Law No 10/1995 which has come into effect since April 1, 1997. The Law accommodates some basic elements to provide, among others, better trade facilitation.
•
Since April 1, 1997, Indonesia has provided an Advance Tariff Classification facility. The facility enables traders and importers to have a written information on tariff classification and import duty rate of goods, which will be imported prior to the lodgment of customs declaration.
•
In April 1, 1998, Indonesia has fully applied the Electronic Data Interchange (EDI) system in some of its main customs service officers.
•
The Tax Appeal Court has been operated since April 1998.
•
Indonesia has fully implemented WTO Valuation Agreement since January 1, 2000 by providing necessary procedure on customs valuation.
•
Indonesia will ratify the Kyoto Convention on he simplification and harmonization of customs procedures, once the Convention is completely revised.
•
Indonesia is in the process of accession to the ATA Convention.
•
Indonesia has applied Harmonized System Convention as a basic nomenclature for its customs purposes.
•
Indonesia is developing Harmonized Trade Data Element in accordance with the implementation of UN/EDIFACT.
•
Indonesia has taken several customs related actions to implement the TRIP’s Agreement by the year 2000.
•
Indonesia also provides necessary information (e.g. brochures) in strategic locations such as airports and seaports, and has introduced the Indonesian Customs Web Site (http://www.beacukai.go.id) and the Indonesian APEC Customs contact point (
[email protected]).
•
Indonesia has further improved the implementation of Risk Management Approach in order to enhance the expeditious flow of goods.
•
In accordance with the main principles of WCO Guidelines on Express Consignment Clearance, Indonesia implements a specific customs clearance procedure called “Rush Handling”.
•
By using Post Clearance Audit Methods, Indonesian Customs Administration intensifies its efforts on combating fraud, particularly in customs valuation area.
In achieving the Bogor goal, Indonesia has been active in the work of the Sub Committee on Customs Procedures. Additionally Indonesia has prepared to work together with all member economies to better simplify and harmonize customs procedures in the region by fully taking into consideration the principles of Facilitation, Accountability, Consistency, Transparency, and Simplification.
- 40 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
4.
Import restriction
(a)
Import licenses
Import into Indonesia maybe conducted only by companies having import license procured from the Ministry of Industry and Trade. To import pharmaceutical products, a company must have import license from the Ministry of Industry and Trade and be registered as a pharmaceutical wholesaler with a permit from the Ministry of Health. (b)
Quotas
Officially, there are no quotas or restrictions in importing pharmaceutical products. Under an emergency situation, however, the Ministry of Health has allocated around US$ 180 million to import pharmaceutical ingredients by an appointed importer. The ingredients are processed into generic medicines for sales to the public and government institutions through usual channels of distribution. (c)
Bans
There are no special arrangements to prohibit import of pharmaceutical products from any country. Indonesia follows the general rules if importation which are WTO compliant. Import licenses are extended to any company incorporated in Indonesia, which can be a limited liability company (PT), a state owned limited liability company (Persero) or a cooperative. Summing up, a company wishing to import pharmaceutical products should have the following: •
A permit as a pharmaceutical wholesaler or a pharmaceutical manufacturer from the Ministry of Health
•
An import license from the Ministry of Industry and Trade
•
Adequate room and equipment to store serums and vaccines
•
Laboratory facilities particularly to test and evaluate serums and vaccines. In the absence of the same, the company concerned should have an arrangement with a laboratory appointed by the Ministry of Health to test serums and vaccines
An import license is non-transferrable. 5.
Investment requirements in general
(a)
General policy
In order to drive investment, general policies of Indonesian Government among others are: •
Government Regulation No.20/1994 and Presidential Decree No.31/95 provide that foreign investors are allowed to acquire 100% shares of the company; and pharmaceutical sector is open for foreign direct investment. A joint venture is only required in eight investment sectors vital to the public interest, such as the operation of harbors, telecommunication, power generator, shipping lines, potable water, public railways and nuclear power generator;
- 41 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
•
The minimum capital requirement for foreign investment has been eliminated;
•
Ministry of Finance Decree No.297/1997 jo.No.545/1997, 546/1997, and 135/2000 provide exemption or deduction of import duty for production machines, equipment and raw materials for new investment. It is also apply to industries which restructuring their production capabilities (such as diversify and improve the quality of the products).
•
Investment application, including approval procedure, has been substantially simplified. Foreign investment’s application with a value of up to US$ 100 million (which formerly needed the President’s approval) is now only subject to the approval or the Minister of Investment/Chairman of the Investment Coordinating Board. The Investment Coordinating Board (BKPM) is now also making the necessary preparations to grant more authority to Local Government Authority to issue investment licenses.
•
Tax incentive to the investor for 22 categories of manufacturing activities. The basic period of enjoying the tax incentive is three years for Java and Bali. Beyond this period the incentive can still be extended up to 12 years maximum if certain requirements are met.
(b)
Equity restrictions/requirements
Government Regulation No.20/1994 provides that foreign investors are allowed to acquire 100% shares of the company established in Indonesia. Therefore, there is no equity restriction implemented in connection with investment regulation in Indonesia. (c) Profit repatriation requirements Not applicable. (d)
Foreign exchange balancing requirements
Not applicable.
G. Export policies and incentives 1.
Export controls
Like Indonesia's import tariff regime, export controls are in a state of rapid change as the government works to implement reforms associated with the IMF program. Many of the restrictions and taxes placed on exports affect agricultural products, including major cash crops like rubber, palm oil, coffee, and copra. Export restrictions and controls are applied by the government to a number of food commodities, most notably crude palm oil (CPO) which remains subject to a 5 % export tax, in an effort to ensure adequate domestic availability and stable prices of such products, particularly with the weak economy in recent years. 2.
Research and development
The Ministry of Finance Decree No.769/1990 provides that Research and Development cost could be deducted from gross income of the company. This policy is to drive companies to do a R&D activity in order to improve performance of the company and to invent new technology.
- 42 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia 3.
Human resources development
The similar incentive is also applicable to those upgrading the capability of their human resources through training activities. This is stipulated in the Decree of Ministry of Finance No.770/1990. 4.
Tax incentive
The Government Regulation No.45/1996 provides the tax incentive to an investor for 22 categories of manufacturing activities. The basic period of enjoying the tax incentive is three years for Java and Bali. Beyond this period the incentive can be extended up to 12 years maximum if certain requirements are met.
H. Import practices In recent years, Indonesia has liberalized its trade regime and taken a number of important steps to reduce protection. Since 1996, the Indonesian Government has issued a series of deregulation packages that have reduced overall tariff levels, simplified the tariff structure, removed restrictions, replaced non-tariff barriers with more transparent tariffs with the aim of encouraging foreign and domestic private investment. 1.
Trade barriers
Despite the severe economic crisis of the past four years, Indonesia has maintained its policy of steady long-term tariff liberalization. Indonesia's applied tariff rates range from 5 to 30 %, although bound rates are, in many cases, much higher. The long-term liberalization policy has been reinforced by consecutive IMF programs in which Indonesia committed to implement a three-tier tariff structure - 0, 5 or 10 % - on all imported products except motor vehicles and alcoholic beverages. Indonesia also committed to eliminate all non-tariff barriers, except those for health or safety reasons, by the end of 2001. Indonesia has liberalized its distribution system, including ending some restrictions on trade in the domestic market. For example, restrictive marketing arrangements for cement, paper, cloves, other spices, and plywood were eliminated in February 1998. Indonesia opened its wholesale and largescale retail trade to foreign investment, lifting most restrictions in March 1998. Some retail sectors are still reserved for small-scale enterprises under another 1998 decree. Large and medium scale enterprises that wish to invest in these sectors must enter into a partnership agreement with a smallscale enterprise although this may not require a joint venture or partial share ownership arrangement 2.
Customs valuation
Since April 1997, the Customs Directorate of the Ministry of Finance has operated a post-entry audit system, which relies primarily on verification and auditing rather than inspection to monitor compliance. A paper-less electronic data interchange system that links importers, banks, and customs was also introduced and is slowly being adopted. Indonesia is in compliance with the WTO Customs Valuation Agreement but U.S. companies operating in Indonesia have reported problems with Customs procedures and valuations made by Indonesian Customs. The U.S. government continues to monitor the situation.
- 43 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
3.
Import licenses and restrictions
According to the Directorate General of Customs and Excise the following goods are still subject to import restrictions, licensing and/or prohibition: narcotics, psychotropics, explosive materials, firearms and ammunition, fireworks, certain books and printed materials, audio and /or visual recording media, telecommunications equipment, color photocopying equipment and parts and equipment thereof, endangered wild fauna and flora and parts thereof, certain species of fish, medicines, unregistered food and beverages at the Department of Health, dangerous materials, pesticides, ozonedepleting substances and goods containing ozone depleting substances, wastes, culturally valuable goods, and other items. In 2000, the Government of Indonesia banned the import of U.S. chicken parts, which has been the basis of a trade dispute between the two countries. Import restrictions and special licensing requirements have been or still are imposed on other goods, such as alcoholic beverages, hand tools, artificial sweeteners, engines and pumps, tractors, rice and lube oil, although such requirements may not be consistently applied. The government controls the import of videotapes, laser discs and other entertainment products for both exhibition and private use. Such goods are subject to review by a censor board. 4.
Import documentation requirements
The government requires the following for most imports: pro-forma invoice; commercial invoice; certificate of origin; bill of lading; insurance certificate; special certificates. According to the Indonesian Customs Law that came into effect in April 1997, importers are now required to notify the Customs Office in the first stage by submitting the import documents on a standard form computer diskette. Customs Inspections of imported goods may be made after they are imported in the importer's warehouse. Typically, the Indonesian importer takes care of the process. 5.
Free trade zones and warehouses/import provisions/temporary entry
The government encourages foreign investors who export to locate in bonded or export processing zones (EPZ). There are a number of EPZs in Indonesia, the most well-known being Batam Island, located 20 km. south of Singapore. Indonesia also has several bonded zones or areas that are designated as entree ports for export destined production (EPTE). Companies are encouraged to locate in bonded zones or industrial estates whenever possible. Other free trade zones include a facility near Tanjung Priok, Jakarta's main port, and a bonded warehouse in Cakung, also near Jakarta. There is a duty drawback facility (BAPEKSTA) for exports located outside the zones. Producers located within the bonded areas are allowed to sell up to 15% of their product into the local market. Foreign and domestic investors wishing to establish projects in a bonded area must apply to the National Investment Coordinating. 6.
Labeling and marketing requirements
Food labeling regulations requiring labels in the Indonesian language and expiration date (rather than the standard "best used by" date) are in place but are not being enforced. A product registration regulation is also in place that requires detailed product processing information so as to approach proprietary information. The registration procedure can also be quite lengthy and expensive. Indonesian importers and US exporters have expressed concern that these regulations could act as non-tariff barriers to imports of packaged food products. - 44 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia The market for foreign pharmaceuticals has been open since the October 1993 Deregulation Package. Previously Indonesia limited pharmaceutical imports to those that incorporated high technology and were the product of their own company's research. The 1993 package also relaxed the registration requirements for pharmaceuticals approved in other countries. Foreign pharmaceutical companies report ongoing problems obtaining timely registration of new products from the Ministry of Health. New regulations issued in July 2000 have helped reduce some of the backlog in new registrations. 7.
Membership in Free Trade Agreements
As a member of the Association of Southeast Asian Nations (ASEAN), Indonesia is party to the ASEAN Free Trade Agreement (AFTA). Through AFTA, ASEAN members are phasing in a Common Effective Preferential Tariff (CEPT) scheme, which will be completed for most traded goods in 2003.
I. Distribution system 1.
Overview
To get a license for a new product, a pharmaceutical company must apply to the Indonesian Department of Health. The procedure takes two months to a year, depending on the product. Companies who apply for a license eventually get one. The main problem is the government bureaucracy, which is sometimes very inefficient. Sometimes "facilitating fees" may have to be paid to officials to get the license easier and on time. This practice is common in Indonesia, although, of course, it is illegal. Foreign companies with U.S. parents face the special jeopardy of the (US) Foreign Corrupt Practices Act in this context. In Indonesia, factories are not allowed to sell their products directly to the consumers or retailers; they must go through wholesalers. There are two major types of retail establishments that distribute pharmaceutical products to the public. Apotik is the Indonesian term for pharmacy, apothecary or dispensary. Apotiks sell prescription drugs and a small number of OTC drugs. Most apotiks are agents of particular pharmaceutical firms. They are highly regulated by the government, and must be managed by certified pharmacists. Toko obats, meaning medicine shops, sell OTC drugs, along with some fakes and illegally imported drugs from the gray market. The products sold by toko obats are usually cheaper than those sold by apotiks. The distribution pattern and the state of the pharmaceutical industry in general is characterized by two distinct government policies that are partially conflicting. On one hand, the government attempts to maximize national capabilities including ownership of pharmaceutical production and distribution, which enable the country to be "self-sufficient" in providing drugs to the people at minimum cost. On the other hand, the Indonesian government, like many others, has been concerned with the safety of drugs offered. Thus, in order to help the "local" pharmaceutical industry to grow and, at the same time, control the quality of drugs in the market, Indonesia banned imports of most medicinal drugs in 1976. Imports accounted for only 2% of the country's consumption of pharmaceuticals by the end of the 1980s. Local producers, therefore, do not have to fear competition from imported products. However, many importers have been known to resort to illegal operations since the government ban on imports. Some wholesale companies, which previously operated as importers, have turned to illicit trade, such as smuggling and/or producing unauthorized imitations in order to survive. - 45 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Products smuggled from Taiwan, Singapore or Hong Kong are not all fakes, but name brand products that are cheaper to import because production costs in those countries are lower. Most of the products sold via the gray market are nonregulated OTC drugs, which are sold by toko obats and wholesalers. Apotiks and hospitals do not buy gray market products. The government has taken some measures against companies found engaged in illegal activities. On the other hand, the government has encouraged previous importers to operate as distributors. Although Indonesia has officially established a system of Patent Rights, there are still lots of fake products in the pharmaceutical market. Some "look alike" brands are still legally permitted, especially those produced by local companies. These products are cheaper than the "originals." There are also some imported fakes from Taiwan and Hong Kong. Most of them are cheaper, and sold by toko obats that have to comply with few regulations in this regard. By contrast, most apotiks do not sell fakes, because there are regulations against selling imitation products. Apotiks caught violating these regulations may be fined or even closed by the government. Producers are largely required to leave the promotion and distribution tasks to wholesale companies. Increasing requirements for wholesale companies to serve as both distributors and promotional agents has made the distribution business more interesting. It is financially attractive because of the relatively low cost, since the pharmaceutical producers pay most of the costs. As the major link between the pharmaceutical industry and the market, the business is relatively safe, due to the continuing demand for drugs. A growing number of companies have been attracted into this line of business. According to one estimate, 50% of the pharmaceuticals produced in Indonesia are distributed through apotiks, 30% are distributed to toko obats and the remaining 20% are distributed directly by practicing physicians and hospitals. Therefore, apotiks play an important role in Indonesia's pharmaceutical industry. There are some 2,211 apotiks registered in the country and are located all over the country, most are on Java. There are 1,150 apotiks on Java, or 68.8% of the total number in the country. Jakarta alone has 318. The number of apotiks increased by 92.2% compared with 1985. Java remained on top with 68%. The role of toko obats is also important. Toko obats sell pharmaceuticals at relatively cheaper prices, often 10% to 20% less than apotiks. Many people therefore, buy from toko obats rather than from apotiks. The number of toko obats operating in Indonesia has also increased. Many of them are not properly registered, although the government has tightened licensing procedures. There exist approximately 2000 registered toko obats, compared to 1201 in 1985. As is the case with wholesale companies and apotiks, Java has the largest number of toko obats. There are 1,012 toko obats on Java, accounting for 50.5% of the total number in the country. Toko obats, however, are spread more evenly than apotiks. Effectively, toko obats serve in the role of apotiks in small towns and rural areas. In addition to OTC drugs, stronger drugs are also available at the toko obats outside metropolitan areas. In these locations, toko obats act like apotiks, and, on occasion, strong drugs are even sold by cigarette retailers on the street (see exhibit below).
- 46 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
2.
Wholesale traders by provinces
Two new decentralization laws, which have recently been enacted: Law no. 22/1999 that deals with provincial and local governments, and Law no. 25/1999 on fiscal equalization between central and local governments—have brought fundamental changes in the basic roles and responsibilities of the central, provincial and district governments. Provincial and district governments now hold more important role in procurement of health services including the public supply of medicines. Therefore, there is an increasing number of pharmaceutical distributors throughout the regions of Indonesia. In 1997, there were only 1,631 wholesale distributors, while in 2000 the number has increased to 2,036 and to 2,470 distributors in 2003.
- 47 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
J. Pharmaceutical sales promotion and pricing Pharmaceutical factories advertise their non-ethical products through the media such as newspapers, magazines, radio and billboards. Ethical products are advertised through medical and pharmaceutical magazines, such as the Index of Indonesia's Medical Services (IIMS), Informasi Spesialis Obat (Indonesia) (ISO), and especially through promotional seminars. Some producers continue to hire "detailers" pharmaceutical salespeople) to promote their products directly to practicing physicians. Such detailing is not always effective, however, because most MDs do not like to meet detailers in person. Instead, doctors tell their nurses to pick up the samples. Then the doctors contact the detailer later by phone.
- 48 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
The government health authorities also discourage the use of detailers because they are considered to be "disturbing the established order." Detailers are no longer allowed to go into hospitals, especially government hospitals. Consequently, most companies now conduct seminars and workshops to introduce new products, rather than use detailers. At these seminars, companies present papers and lab results in conjunction with marketing their products, as is the practice in industrialized countries. Also, as in the developed countries, manufacturers promote products containing the same active ingredients under different names and labels, in order to segment the market. Promotion costs are high and constitute an important factor in price calculations. Some estimates in the industry point that promotional costs account for up to 30% of the price. The long distribution line is also a factor in pricing. Under the current system in Indonesia, pharmaceutical factories distribute their products through a wholesaler in order to service apotiks, toko obats and hospitals. 1.
Pricing pharmaceutical products
According to a regulation set by Indonesia's Food and Drug Supervision Directorate General, an apotik (dispensary) is to sell its product at a price 1.425 times the buying (net) price (see the section, Distribution System of Pharmaceutical Products in Indonesia for a description of retail establishments distributing pharmaceuticals to the public). A description of the price calculation system used can be summarized as follows.
- 49 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Source: Various Sources (processed)
In Indonesia there are only 3000 apotiks and toko obats to service the country's 210 million people. Complicating the matter further, most Indonesians live in rural areas, whereas most apotiks and toko obats are located in cities. Consequently, rural people obtain drugs from government-run health centers, called Puskesmas and Pos Yandu. A Puskesmas is a subdistrict public health center served by two or three "junior" doctors and nurses. It is not well equipped and cannot treat severe illness, but provides adequate services for general sickness and first aid before patients can be treated at a hospital. A Pos Yandu is a rural area public service center that functions as a multipurpose service and firstaid post. Its’ staff typically includes a nurse and several social workers, but no doctor. It also serves as an information center for government family planning, nutrition and welfare programs.
- 50 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
K. Maritime transport services 1.
Availability
Indonesia is heavily dependent on maritime transport for international as well as for domestic trade. The development of shipping and port services throughout the country has long been a priority of the Indonesian government, and mainly influenced by the development of surrounded strategic environment Over the years, Indonesia’s maritime industry has evolved from a very extensive public sector involvement and restrictive licensing and regulatory regime to a much more liberalized and decentralized system. Deregulation of the maritime sector started in 1985 and has progressed to the current stage where it allows foreign shipping lines to call at all ports in the country which are opened for international trade. In addition, Indonesia has no bilateral/unilateral cargo reservation schemes except for “cabotage” and specific government cargoes, and also accords no different treatment for overseas vessels to access to/use of port facilities. The above measures reflect the liberalization policy on maritime transport services has created an extensive network of shipping services provided by a large number of foreign shipping lines and a few domestic shipping lines, which have supported the country’s growing international trade. This is part of the entire deregulation program in various economic sectors such as trade in goods, taxation, finance, investment, monetary and other sectors. From 1996 to 2000, the number of shipping companies has increased. From 1,156 companies in 1996 to 1,724 companies in 2000. In the same period, from 1996 to 2000, the number of national merchant fleet increased from 6,156 units in 1996 to 9,196 units in 2000. The volume of sea born trade also increase by the average growth of 3% per annum. In 1996, the volume of cargo by sea transport amounted to 365,634,280 tons. While in 2000, it increased to 417,287,411 tons. 2.
Suitability
Indonesia’s infrastructure is well developed around the population centers on Java, Sumatra, and Bali. In these areas, there are substantial road and rail connections for both passenger and freight transport. Outside of the major cities, however, the surface transportation infrastructure is not as advanced. Because Indonesia is an archipelago, sea transport of raw materials and agricultural goods is extremely important and well developed. Each of the major islands has at least one significant port city, and on Java and Sumatra, The principal ports are Jakarta, Surabaya, Semarang and Cirebon on Java, Belawan-Deli and Palembang on Sumatra and Ujungpandang in Sulaweisi and Merauke in West New Guinea. Jakarta Container Port (JCP) is Indonesia's largest container terminal and comprises both Jakarta International Container Terminal (JICT) and KOJA Terminal. JCP is strategically located in the industrial heartland of West Java and serves as Indonesia's national hub port. A redevelopment project of is currently underway which will increase JCP's annual handling capacity to over 3 million TEU. JCP plans to construct an additional 300 meters of berth with a depth alongside of 14 meters below chart datum and a further 32 hectares of back up area. The upgrading and expansion of JCP will further contribute to Indonesia's economic development.
- 51 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
L. Packaging 1.
Indonesia’s Packaging Industry and Methods of Packaging
In line with the fast growth of the consuming industries like the food and drink industry, the cosmetics and pharmaceutical industry, the electronic and electrical household appliance industry, the furniture industry, automotive component industry, building material industry and many other industries using packaging, Indonesia’s packaging industry is still quite attractive to investors. This development is in line with the increasing demand for packaging paper used to pack light and heavy products. Besides, the packaging industry has also improved in performance prodded by development of the function of packaging from just packaging proper into means of transmitting information and as means of promotion at the same time for the product concerned. According to The Capital Investment Coordinator Board (BKPM), for the last two years (1998 u 1999) five investors joined the paper packaging industry, with a planned investment of Rp 41.1 billion. During the period of January to August 1999, four foreign investment projects (PMA) with a total investment of US$ 11.6 million were implemented. The above development has turned the packaging industry into a rich business ground for suppliers of products, from the main raw materials down to auxiliary materials, such as cardboard and kraft paper, plastic film, plastic sheets, aluminum foils, adhesive, printing ink, etc Among the six packaging types – steel, aluminium foil, paper, board, plastic and jute – paper and board are the leading materials. These materials have a 71% market share, from 51% in the early 1990s. The Indonesian industry is able to service its market in terms of quantity, but despite some improvement, the quality of some of the products is inadequate. There is increasing pressure for more environmentally friendly materials to be used for packaging. Paper and board, which are regarded as far more manageable than plastic and metal, have given rise to an estimated paper and board consumption in 1996 of 700,000 tonnes. The jute industry is also being revived. This is a direct result of environmental concerns or "green"campaigns. Currently, demand for packaging paper materials, both board paper and specific packaging paper, is mostly supplied by local producers. During the last five years (1994 u 1998), production of the two material types had increased from 767,000 tons in 1994 to 1.3 million tons, an increase of 15.0% per year. The largest increase occurred in 1996, from 809,040 tons in 1995 to 1.07 million ton, or a 32.8% rise from the previous year. 2.
Paper and board
Paper and board demand in Indonesia showed strong growth before 1997. In 1997, consumption reached 4.2 million tons. Indonesia managed to achieve an increase in paper and board consumption in 1998 as well. However per capita paper and board consumption was low by world standards, at 5.5/kg/yr in 1998. But paper and board demand was hit hard by the economic slowdown of 1998 which deepened into sharp recession in 1999. In that year, paper and board sales shrank sharply. Indonesia's good economic result for 2000 helped to rescue paper and board demand. At the end of 2001, total paper and board demand in the country was still below pre-crisis highs. But the economy was on track to drive this indicator beyond the pre-crisis peak by 2002.
- 52 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Indonesia’s comparative lack of purchasing power has meant that it is not always capable of obtaining the leading edge machinery, which would make it competitive in the world arena. Indonesia does not only require machinery, but also training and staff development. Packaging is a labour intensive industry, so Indonesia will continue to benefit from its abundant supply of inexpensive labour. The paper and paperboard industry is highly dependant on the pulp and paper industry. Despite the sluggish growth in the country's overall economic condition, the pulp and paper industry in Indonesia has enjoyed an average annual growth of eighteen % for the last five years. Moreover, according to the Indonesian Central Bureau of Statistics, pulp imports were ranked as number seven among the top ten import commodities in Indonesia in 2000. The total import of pulp products reached US$ 1.1 billion in 2000, an increase of 65% from 1999 at US$ 647 million. The industry's growth is supported by the high export volume of paper products to various countries in the world, as a result of the collapse in the value of Rupiah and low local consumption rates. According to the Indonesian Pulp and Paper Association (APKI), the national paper consumption was only 3.9 million metric tons in 2000, although this was a fourteen % increase from 3.4 million metric tons in 1999. 3.
Corrugated carton boxes (CCB)
Corrugated carton boxes (CCB) are typically multi-layer boards used for folding carton packaging. CCB is considered as a commodity and is mostly used in consumer and agricultural industries for packaging purposes. The main raw material of CCB is waste paper produced by the paper industry. The industry is a capital intensive one that is impacted by the development of technology resulting in improvements in product design and properties (e.g. strength). Indonesia is a main consumer and leading of exporter of CCB in the Asia-Pacific region. Indonesian CCB producers are also leaders in regional CCB production. Indonesia has a competitive advantage in the industry due to an abundant supply of pulp and paper from its tropical forests, complemented by its cheap labor costs. Local companies, however, are far behind their global rivals in terms of technology applied in their business. USA, Japan, Germany, France, Italy, and the UK therefore account for 50% of the world’s packaging. The carton box has been produced in Indonesia since the 1970s and started to expand enormously in the 1990s caused by the fast growing manufacturing sector. The industry is also opened to foreign investors and many importers import the products from other countries (subject to an import duty of 10%). 4.
Producers and capacity
Currently, in Indonesia there are 108 companies engaged in the industry with a total installed capacity of 1.9 million tons per annum and an average utilization rate of 65%. About 75% of the companies are small to medium size companies. Most of the producers are located in Java particularly in Jakarta and its surroundings, driven by market demand from consumer industries also located in the same area. Besides local production, the country also imports CCB from other countries (in small volume), mainly from the Philippines and USA. Imported products generally are of higher quality than the local products and are mostly used for packaging of export commodities.
- 53 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
5.
Raw material availability and vertical integration
Raw materials for CCB are linerboard, medium paper and kraft liner, mostly produced by local paper mills. Raw materials represent 50% to 70% of the cost of goods sold. Thus, raw material cost fluctuations remain an inherent risk in the packaging industry, including, the CCB industry. Paper prices are based on pulp prices and are very cyclical driven by its nature as a commodity product. If raw material prices increase, packaging companies may experience a margin and profit squeeze due to the difficulty in passing on the increased production costs to customers in a timely manner. 6.
Competition
The industry now is facing increasing competition from larger producers with the ability of vertical integration forcing some small to medium size companies to stop production and close their businesses. Currently, many of the remaining companies are seeking to increase their production capacity, which might result in excess supply in the next few years. Competition comes from the mini box industry, which usually have better printing machinery to produce higher quality products, but with higher prices than CCB products. Competition also comes from recycled board box producers whose products have been used extensively in the Asia Pacific region caused by more concerns over environment. However, the recycled board box is not popular in Indonesia at the moment since the raw material for recycled board box is still imported with 15% higher cost than CCB’s raw material cost. The following figures reflects on corrugated production/shipments (million square meters) for the full year 2001 with comparisons to 2000. Indonesia’s production for CCB increased substantially by 17.3%.
Source: Worldwide Corrugated Packaging industry statistics report, 2001
7.
Plastic and flexible packaging
Plastics usage in Indonesia after the economic recession has experienced only adequate growth. The consumption of PE (polyethylene), PP (Polypropylene), PS (polystyrene) and PVC (PolyVinyl Chloride) plastics in 2000 had again reached 1.6 million tons. When the economic crisis hit in 1998, consumption of plastics decreased by more than 40% from the year before, dropping to 900,000 tons. The recent recovery in the sector was accelerated by strong demand from food and beverages industries. - 54 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia The flexible packaging industry generally using as raw material plastic film like BOPP film, PET film, PVC film, aluminium foil, CPP film, etc. has up to now been faring quite well. In the prolonged economic crisis situation most companies in the industrial sector have been struggling to stay in business by pressing down production cost as much as possible. And the use of flexible packaging has been found to be one solution. Besides being practical and presenting a nice appearance, the use of flexible packaging can help lower production cost. In Indonesia there are now no less than 60 flexible packaging producing companies with a total capacity of 106,605 tons per year. In 1999 production realization was registered at some 64% of capacity and in 2000 projected at no less than 70% of capacity. Several companies in this industry, particularly of the big category, have been able to achieve a real output of above 80%. But there are also companies with an output rate of under 50% of capacity. In all, the production of this industry in 1999 was valued at Rp 1.3 trillion. The food industry sector has been the biggest consumer of flexible packaging, with an intake of 66.2% of total consumption in 1999, with the pharmaceutical & cosmetics industry and other sectors accounting for 33.8% of total consumption. Of the food industry, the biggest flexible packaging users are the instant noodle industry, the snack industry, biscuit industry and candy industry. 8.
BOPP plastic
BOPP film is a high performance biaxially oriented, specialfilm made from polypropylene. It is primarly used by the packaging industry in packaging, adhesive tapes, capacitors, textile outwrapping, lamination, cigarette wrapping and reverse printing. The consumers of BOPP films vary widely. Cigarettes companies are the largest industrial consumer of BOPP films, followed by instant noodle producers, biscuit producers and manufacturers of confectioneries. These companies however do not order directly from the BOPP producers. Instead, the BOPP films are ordered from companies, which convert the BOPP film into the finished product from the raw material. Since its introduction in the 1960’s, BOPP has been well applied in the packaging industry. In 1997, there were 187 companies worldwide engaging in BOPP film production, such as Mobil of USA, ICI of the UK and Toyobo of Japan, with an output of over 2.5 million tonnes. In Indonesia, there are at least nine companies that produce BOPP film with total production capacity of 123,000 tons per annum 9.
Overall packaging remains strong
Indonesia saw a surge of investment activity in packaging during the past decade. Most of the country's packaging production is destined for domestic consumption. The expansion and diversification of Indonesia's manufacturing sector has been the main driver behind this strong demand trend. Demand for corrugating materials was affected by the 1998 economic slide, but the sector suffered less than other grades of paper and board. Manufacturing growth has also been a key driver behind the rise in production and consumption of boxboard.
- 55 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
M. Export credit and finance 1.
Brief description of banking system
The Indonesian banking system comprises of Bank Indonesia, as the central bank, state banks, private banks, foreign banks and joint venture banks, while non-banking financial institutions consist of leasing, venture capital, factoring and the insurance business. The banking industry has rapidly developed after the issuance of several regulations aiming at liberalizing the banking sector. Next to the banking sector the government has privatized the Jakarta Stock Exchange in 1992, which then became an important source of capital for Indonesian enterprises. The goal was to achieve higher efficiency in the mobilization and channeling of funds to various investment projects. These reforms were immediately welcomed by investor giving birth to dozens of new banks that rapidly spread throughout Indonesia. When the economic crisis hit Indonesia in 1997, it was the banking sector, which received the hardest impact arising from the sharp depreciation of the Rupiah. This fluctuation was worsened by the fall of the construction and property industry causing bad loans to soar and leaving a financial drought within major players in this industry. Therefore, Indonesia's banking system has only partially recovered from the crisis, and many banks remain technically bankrupt or are hamstrung by very low capital reserves. Unprecedented levels of corporate debt have limited the ability of many private sector firms to obtain trade or project financing, and the cost of imported capital goods has risen substantially in the wake of the Rupiah's devaluation. These economic factors coupled with lingering political instability have led to steep declines in both imports and direct foreign investment, and private capital inflows have remained strongly negative since 1998. Banks were at ground zero of the 1997-98 financial crisis. When the smoke cleared, the total number of banks had declined from 238 pre-crisis to 162 (5 state-owned national banks, 27 state-owned regional development banks, 120 private banks, and 10 foreign branches, not counting joint-venture banks and foreign banks' representative offices). The Government of Indonesia (GOI) launched a massive bank recapitalization program in 1999 that has stabilized the banking sector but is not yet completed. While the banking sector is no longer in a state of collapse, it has not yet recovered to precrisis levels, and several large state-owned banks continue to lose money. Banks remain reluctant to make new loans outside of the consumer sector, leaving the interest earned on bank recapitalization bonds as the prime source of income for many. While local banks are not expected to return to normal levels of business in the near-term, lending by foreign banks and joint venture banks has resumed on a modest scale to selected customers, primarily exporters. Corporate loan restructuring has progressed very slowly, and most Indonesian firms find that obtaining trade and project financing has become significantly more difficult. Many local companies can neither meet requirements for new loans nor service their existing bank debt. Letters of credit remain difficult to come by and can face difficulties in gaining acceptance abroad. Despite lagging progress on bank and corporate debt restructuring, the Indonesian economy has shown some signs of recovery. According to the World Bank, the GDP growth stood at 3.5% and 4.0% for the years 2002 and 2003 respectively. Inflation and interest rates have declined dramatically from their mid-crisis levels, but are showing signs of increasing again. Improved export earnings have enabled Indonesia to have a positive current account balance. - 56 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia The GOI (Government of Indonesia) has accumulated foreign exchange reserves above the targets set in its IMF program. Continued improvement is the indicators will strengthen the overall lending environment, and if sustained, could lead to increased demand for trade financing in the mid-term as well as enhanced opportunities for exporters. 2.
Foreign exchange controls affecting trade
Bank Indonesia introduced new foreign exchange regulations in January 2001 that have significantly cut back the flow of Rupiah to offshore markets. The regulations place limits on the quantity of Rupiah that onshore banks may transfer to offshore parties without underlying trade or investment transactions. These limits, currently set at US$ 3 million, apply to both each transaction and to a bank's cumulative derivative transaction position, including forward sales, swaps, and option contracts. Despite the new restrictions on offshore transfers of Rupiah, Indonesia has no system of capital controls and foreign exchange flows freely in and out of the country. No prior permits are necessary to transfer foreign exchange. Foreign investors have the right to repatriate capital and profits at the prevailing rate of exchange. The government does not place restrictions on outward direct investment. Foreign Exchange Law No. 24/1999, which entered into force in April 2000, requires the reporting of all foreign exchange transactions above US$ 10,000. 3.
General availability of financing
In June 2000 Bank Indonesia (BI) announced a package of regulatory changes designed to encourage bank lending, including trade financing. These measures include amendments to BI's prudential regulations concerning the recalculation of capital-asset ratios to permit additional credit expansion. A second amendment to the prudential regulations extends until May 2001 (or December 2002 for loans restructured through the Jakarta Initiative) the time limits by which all banks must comply with BI's legal lending limit (the limit concerns the %age of bank credit which may be allocated to individual firms). A third BI circular relaxed the requirement that banks liquidate equity positions in a debtor company after 5 years or when the company achieves net profits in two consecutive years (the latter provision was changed to require divestment only once a company achieves a cumulative profit). Prior to the financial crisis, a large number of Indonesian banks maintained correspondent relationships with American banks. However, given the fundamental restructuring underway in the banking system, many of these relationships are no longer in effect. With the sharp drop-off of private capital flows since the economic crisis, Indonesia is now heavily dependent on official financing, primarily from the Asian Development Bank (ADB), World Bank, and major bilateral donors. The World Bank, ADB, and other multilateral and bilateral donors meet periodically in the Consultative Group on Indonesia (CGI). 4.
How to finance exports/methods of payment
Since the onset of the crisis, the Government of Indonesia has taken a number of steps to encourage private sector lending. Indonesia retained an open capital account with no foreign exchange controls both during and after the crisis. The May 1999 foreign exchange law requiring banks and other businesses to report large foreign exchange transactions for monitoring purposes has not had a significant effect on capital flows.
- 57 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia The GOI has also implemented specific measures aimed at increasing the supply of trade financing, including: Establishment of a US$ 1 billion collateral fund deposited offshore to encourage acceptance of Indonesian letters of credit (set up in mid-1998); Government insurance for repayment of trade financing extended by Indonesian banks (set up in late 1998, but little used); Establishment in July 1999 of Bank Ekspor Indonesia, a Trade Maintenance Facility arising from the June 1998 "Frankfurt Agreement" (renewed in May 2000). Creation of a $1 million short-term credit guarantee program in collaboration with foreign export credit agencies, including the US Export-Import Bank. 5.
Types of available export financing and insurance
Prior to the financial crisis, all forms of import and export financing were available in the Indonesian market and frequently used, although most imports were financed with letters of credit. Short-term financing was readily available. Some larger banks were providing longer-term financing of up to 2-3 years. Indonesian buyers have generally preferred the supplier to provide the necessary financing for a commercial transaction, either normal commercial trade financing or export credits from the source country's export credit agency (for e.g in the case of the United States, the US Ex-Im Bank located in Washington, D.C.). Local bank financing has sometimes been arranged, depending on the customer or the agent/distributor involved in the transaction. Once the economy recovers, proposed reforms in the banking sector should make local financing a more favorable option than it has been in the past. Several American banks have shown initiative in arranging trade-financing packages for their customers, some with Ex-Im Bank guarantees. Although U.S. Ex-Im, along with other export credit agencies and foreign banks, is not processing applications in Indonesia currently, once bankers have a reasonable assurance that stability is returning to Indonesia, investors will rely on creative financing options more than ever. Indonesia now secures a substantial portion of its development funding from the multilateral development banks, primarily the Asian Development Bank (ADB) and the World Bank. Indonesia will rely on this assistance to a larger extent.
N. Trade promotion 1.
Ministry of Trade and Industry (http://www.dprin.go.id)
The Ministry of Trade and Industry's mission is to promote Indonesian small and medium enterprises to the global market place. It is also the coordinating and regulatory agency for counter trade deals. 2.
National Agency for Export Development (http://www.nafed.go.id)
The Indonesian Government established the National Agency for Export Development within the Ministry of Trade to promote the export of less renowned products. These products include handicrafts (i.e., jewelry, batik, hand-woven fabric, and wood carvings), agricultural and cottage industry products, and new manufactured products. The agency will also assist foreign buyers and importers in establishing contacts with Indonesian companies.
- 58 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia The role of the NAED involves coordinating, encouraging and implementing the development of national export through market information services and implementation of export promotion. The mission of Nafed are as follows: •
To formulate policy and establish guidelines for encouraging and supporting the expansion of nonoil and gas exports
•
To provide information services and market co-ordination
•
To implement and co-ordinate export promotion
•
To expand the range of export products and markets
The Agency maintains a database of thousands of Indonesian manufacturers classified by product as well as another database of foreign buyers who may be of interest to Indonesian exporters. All NAFED services are free of charge and, as a non-profit organization, NAFED acts as a facilitator linking buyers and sellers. The Agency places special emphasis on expanding the export of non-oil and gas commodities, for years once the mainstay of the economy. It is proactive in identifying manufacturers with suitable products for sale overseas as well as identifying new markets overseas. A substantial portion of Indonesia s export growth is a result of the activities of NAFED together with private companies in penetrating new and non-traditional markets. NAFED s goal is to assist the Indonesian business community and the country s exporters in particular, to produce and export products which attract market interest and fulfill market demands. An important means of achieving this is the product adaptation and development programme, which is undertaken through technical support from domestic and international experts and co-operation between Government, private sector and university institutions. 3.
Indonesian Chamber of Commerce and Industry (http://www.kadinnet.go.id) (KADIN)
The major trade association in Indonesia is the Indonesian Chamber of Commerce and Industry (KADIN). Members include representatives from private industry, cooperatives, public corporations, utilities, as well as state-owned enterprises. In addition, there are numerous other specialized and professional organizations that represent the interests of various other sectors and trades in the economy. Business and government leaders of Indonesia officially established the Indonesian Chamber of Commerce and Industry in 1968 as a result of the joint efforts. The KADIN is an independent, nongovernmental, non-profit making economic/business organisation - the sole organisation uniting Indonesian entrepreneurs and the business world, representing all private enterprises and State enterprises. As an economic organisation uniting national entrepreneurs, the KADIN consists of (Central) KADIN Indonesia, KADINDA, business/trade Associations, the 'Himpunan' or other national economic organisations and the Committees of Foreign Economic Cooperation. It also serves as a forum and a facilitator for promoting and enhancing the vital roles of businessmen in Indonesia, increasing business interaction and enhancing regional economic growth.
- 59 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Kadin Indonesia directs its activities to bridging the gaps which exist among the entrepreneurs and functions as a mediator between business communities and the government. With economic cooperation as one of its main focus, Kadin Indonesia regularly holds various kinds of meetings, workshops, issues publications and establishes an information network to facilitate contact and exchange of information among businessmen. Indonesia has brought thousands of business leaders and key entrepreneurs from all parts of the world into personal contacts, business meetings and one on one meetings. Kadin Indonesia provides direct services to 26 provincial chapters and more than 300 regencies' branches. It is constantly reviewing its activities to be relevant to the situations. It is constantly reviewing its activities to be relevant to the situations. Over 200 business associations are part of the Chamber structure. To coordinate its activities with other countries or regions, Kadin Indonesia established committees, bilateral or multilateral, and forms linkage and collaborates with key regional and international groups and chambers, both private and governmental, whose objectives and purposes are similar to its own. 4.
GP Farmasi (Gabungan Perusahaan Farmasi Indonesia) / Indonesian Association of Pharmaceutical Companies (www.gpfarmasi.org)
GP Farmasi is the reference point for the pharmaceutical industry in Indonesia. In its present form it came into existence on the 19th August 1969. The association has the following constituents: •
G.A.S.I (Gabungan Apotik Seluruh Indonesia) – Pharmacy/Dispensary Association
•
P.I.PH.I. (Persatuan Importir Pharmasi Indonesia) – Pharmaceutical Importers Association
•
G.A.F.I (Gabungan Industri Farmasi Indonesia) – Pharmaceutical Industry Association (others including manufacturers)
The objectives of the association are to promote sharing of the pharmaceutical domain knowledge within the economy, and to contribute to the development of the national economy by providing inputs to the government (on matters concerning healthcare and the pharmaceuticals industry). As of September 2002, GP Farmasi’s members only include firms with legal operating licenses, comprising 198 manufacturers, 2,500 distributors, 6,500 dispensaries and 5,000 drug stores.
O. Conclusions and recommendations 1.
Overview
The pharmaceutical industry in Indonesia has been well established compared with other industries in the country. It has particularly developed since 1955 when there were only seven pharmaceutical plants in the country. It then began to grow significantly in the 1960s, especially after the introduction of the Foreign Capital Investment Law in 1967 and the Domestic Capital Investment Law in 1968. Already in 1966 this number had risen to 130. The number of plants continued to increase after the introduction of the Investments Law. By 1975 there were 230 factories, in 1984 there were 273 and in 1988 the figure rose to 285, and currently there are 198 such plants (the 1997 economic crisis being responsible for the decline in the numbers). - 60 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia The development of the pharmaceutical industry was paralleled by other related businesses, such as wholesalers. Given the distribution of population, skills and infrastructure, it is not surprising that most of Indonesia's pharmaceutical plants are located in Java. In 1955, 243 or 88.7% of pharmaceutical plants operating in Indonesia were located in Java (currently 93.4%), with the largest number in Jakarta and West Java. These two regions had a total of 159 factories in 1985 (currently 130), East Java had 49 (currently 54), Central Java had 31 (number unchanged to the current period) and Yogyakarta had 4 (currently 5). Outside Java, North Sumatra topped other regions with 16 factories (currently 10). Of interest to a foreign company aspiring to enter the Indonesian market would be the tally of the 40 foreign joint venture companies, although small in number, have established a strong market share in Indonesia. Most of them are multinational companies. (see table below)
- 61 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Source: P.T. Corinthian (CIC)
2.
Market and types of products
The market for medicines depends largely on the pattern of the common diseases in a country. In tropical and developing countries, infectious diseases are the most common. For example, each year, 5.3 million Indonesians suffered from upper and lower respiratory tract diseases. Tooth and gum disease are second in prevalence, attacking 8.0% of the population. Skin and hypodermic diseases are third, accounting for 7.5% of cases. Eye and adnexa diseases amount to 6.2% and cardiovascular diseases for 2.6%. This composition has not changed much during the last several years, with one exception: upper and lower respiratory tract cases have increased from 38.3% in 1987 to 41.0% in 2003 (possibly due to the considerable air pollution in all population centers). Apotik sales of medicines reflect the characteristics of the pharmaceutical market in Indonesia. Antibiotic sales from apotiks accounted for 26.3% of the country's total sales of pharmaceuticals, topping other pharmaceuticals in sales. Respiratory system drugs are the second largest selling group of pharmaceuticals, sharing 12.6% of the country's total sales of pharmaceuticals. These two pharmaceuticals make up 38.9% of the country's total drug sales. This %age corresponds to the pattern of common diseases in the country. Drugs for the neuromuscular system held 11.6% of the pharmaceutical market, placing third in sales followed by vitamins and minerals, which shared 10.3% of the market. Details are shown in the table below.
- 62 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
3.
Market share of pharmaceutical products (by sales)
Source: P.T. Corinthian (CIC)
- 63 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
4.
Recommendations
(a)
Exporting
For a company at the beginning of the learning curve (re the Indonesian pharmaceutical market), exporting through pharmaceutical wholesalers in Indonesia is good strategy before committing greater resources to the market. (b)
Establishing pharmaceutical plants in Indonesia (supplied with imported basic ingredients)
The large market demand for pharmaceutical products has not encouraged investment in basic ingredient manufacturing. About 95% of the basic ingredients are supplied through imports; only 5% come from local sources. Despite government encouragement, no domestic investor has been interested in venturing into the pharmaceutical basic ingredients industry. Technological and marketing problems, coupled with the difficulties of obtaining manufacturing licenses from foreign principals, are among the obstacles discouraging investors from committing to this business. Foreign joint venture companies receive basic ingredient supplies from their parent companies abroad and, without government requirements, would most likely eliminate their costly chemical plants in Indonesia. Imports are expected to fill the basic ingredient supply in the future. This is the strategy taken by many multinational companies in Indonesia (Merck, Bayer, Glaxo, Schering, Squibb, etc.) i.e. to set up a pharmaceutical plant in Indonesia, which is supplied by basic ingredients and raw materials that they produce overseas. Such captive local plants are least affected by changing supply conditions barring the economic crisis (which skyrocketed the costs of imports), and are stronger than the local pharmaceutical companies. (c)
Establish a plant to produce active ingredients
Finally a company can enter the Indonesian market by establishing a plant to produce active (basic) ingredients. Notwithstanding the tremendous government support such a venture is anticipated to receive, the problem of economies of scale would be paramount. The relatively small active pharmaceutical ingredient market in Indonesia raises the question of profitability of such a plant, and an entrant under this mode would need a complimentary strategy of exporting (active ingredients) from its Indonesian base. For a multinational company, the following exhibit best encapsulates the target and strategy for the Indonesian market.
- 64 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
ÕÕÕ
N. Useful Addresses 5.
Government bodies and industry associations
Ministry of Industry And Trade - The Republic of Indonesia Jl. Gatot Subroto Kav. 52-53, Jakarta 12950, Indonesia Phone: (62-21) 5252194 Facsimile: (62-21) 5261086 E-mail Address:
[email protected] Website: www.dprin.go.id Ministry of Health Jl. H.R. Rasuna Said Blok X/5 Kav 4-9, Jakarta, Indonesia Phone: (62-21) 5201590 Website: www.depkes.go.id Directorate General of Drugs and Food Control Jl. Percetakan Negara No. 29, Jakarta, Indonesia Phone: (62-21) 4245459, 4244755, 4244691, 4244688 Directorate General of International Trade Jl. Gatot Subroto Kav. 52-53, Jakarta, Indonesia Phone: (62-21) 3860940, 3858195, 3858201, 3858194
- 65 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
GP Farmasi / Indonesian Association of Pharmaceutical Companies Jl. Angkasa No. 20 A Kemayoran, Jakarta Pusat – 10260, Indonesia Phone: (62-21) 4203040 Facsimile: (62-21) 4203047/48 Email:
[email protected],
[email protected] Website: www.gpfarmasi.org Indonesian Chamber of Commerce and Industry (KADIN) Gedung Chandra 3rd Floor, Jl. M.H. Thamrin 20, Jakarta 10350, Indonesia Phone: (62-21) 324000 Email Address:
[email protected] Website: www.kadinnet.com National Agency For Export Development (NAFED) Ministry of Industry and Trade, Jalan Gajah Mada No. 8, Jakarta 10310, Indonesia Phone: (62-21) 634 1082 Facsimile: (62-21) 633 8360 Email Address:
[email protected] Website: www.nafed.go.id Central Bureau of Statistics Jl. Dr. Sutomo 6-8, Jakarta 10710, Indonesia Phone: (62-21) 350 7057 Facsimile: (62-21) 385 7046 Website: www.bps.go.id Investment Coordination Board (BKPM) Jalan Jenderal Gatot Subroto No.44, Jakarta 1210, Indonesia Phone: (62-21) 525 2008 Facsimile: (62-21) 525 4945 Email:
[email protected] Website: www.bkpm.go.id MINISTRY OF HEALTH (DEPARTEMEN KESEHATAN) Minister of Health : Dr. Achmad Sujudi, Sp.B, MHA Jl. HR Rasuna Said Blok X-5 Kav. 4-9, 2nd floor Block A Jakarta Pusat Phone: (021) 5201587, 5201591 Sentral: (021) 5201590 Fax: (021) 5201591 Advisor on Pharmaceutical Medical : Drs. Richard Panjaitan, Apt. SKM Jl. HR Rasuna Said Blok X-5 Kav. 4-9, 2nd floor Block B Room 218 Jakarta Pusat Phone: (021) 5223017
- 66 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Secretary General : Dr. Dadi Sugandi Argadiredja, MPH Jl. HR Rasuna Said Blok X-5 Kav. 4-9, 2nd floor Block A Room 209 Jakarta Pusat Phone: (021) 5201587, 5201591 5201590 (Hunting) ext. 2000, 2002 Director General for Community Health : Prof. Dr. Azrul Azwar, MPH Jl. HR Rasuna Said Blok X-5 Kav. 4-9, 2nd floor Block B Jakarta Pusat Phone: (021) 5203871, 5201590 (Hunting) ext. 2200, 2201 Email :
[email protected] Director General of Medical Services: Dr. Sri Astuti S. Soeparmanto, M.Sc.PH Jl. HR Rasuna Said Blok X-5 Kav. 4-9, 2nd floor Block B Jakarta Pusat Phone: (021) 5203872, 5201590 (hunting) ext 2300 Email:
[email protected] Director General of Communicable Disease Control: Prof. Dr. Umar Fahmi Achmadi, MPH, Ph.D. Jl. HR Rasuna Said Blok X-5 Kav. 4-9, 2nd floor Block A Jakarta Pusat Phone: (021) 4209930 Facsimile: (021) 4207807 Director General of Pharmacies and Health Equipment Services: Drs. Holid Djahari, Apt. MM Jl. HR Rasuna Said Blok X-5 Kav. 4-9, 2nd Block B Room 220 Jakarta Pusat Phone: (021) 52964838, 5201950 (hunting) ext. 2029 Director General of Pharmacies Development Community and Clinic: Drs. Abdul Muhid, Apt. Jl. HR Rasuna Said Blok X-5 Kav. 4-9, 4th floor Block B Jakarta Pusat Phone: (021) 5201590 (Hunting) ext. 4307 Director of Rational Medicine Application: Dr. Husniah Rubiana Thamrin Akib Jl. HR Rasuna Said Blok X-5 Kav. 4-9, 6th floor Block B Jakarta Pusat Phone: (021) 5201590 (hunting) ext. 6309 Director of Public Medicines and Logistics: Drs. Bahron Arifin, Apt. Jl. HR Rasuna Said Blok X-5 Kav. 4-9, 5th Block C Jakarta Pusat Phone: (021) 5201590 (hunting) Director for Production and Distribution of Health Equipment: Drs. Tato Suprapt Basir, MM Jl. HR Rasuna Said Blok. X-5 Kav. 4-9, 7th floor Block C Jakarta Pusat Phone: (021) 5201590 (hunting) - 67 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
NATIONAL AGENCY FOR DRUGS AND FOOD CONTROLS – BADAN PENGAWASAN OBAT DAN MAKANAN (BPOM) Chairman : Drs. H. Sampuno, MBA Jl. Percetakan Negara no. 23 Jakarta Pusat 10560 Phone: (021) 424 4688 Facsimile: (021) 425 0764 Email :
[email protected] Website : www.pom.go.id Primary Secretary (Sekretaris Utama) : Mrs. Mawarwati Djamaluddin Jl. Percetakan Negara no. 23 Jakarta Pusat 10560 Phone: (021) 424 5331 Facsimile: (021) 424 4947 Email:
[email protected] Deputy I Theurapetic & Narcotic Inspection : Dra. Lucky S. Slamet, M.Sc. Jl. Percetakan Negara no. 23 Jakarta Pusat 10560 Phone: (021) 424 5459, 424 4755 ext. 103 Facsimile: (021) 424 3605 Email:
[email protected] Deputy II Therapeutic & Narcotic Inspection : Drs. Ruslan Aspan, MM. Jl. Percetakan Negara no. 23 Jakarta Pusat 10560 Phone: (021) 4288 4208 Facsimile: (021) 4288 4208 Email:
[email protected] Director of Therapeutic Product Standardization : Mr. Udjianto Jl. Percetakan Negara no. 23 Jakarta Pusat 10560 Phone: (021) 424 5459, 424 4755 ext. 105 Facsimile: (021) 424 3605 Email:
[email protected] Head of Sub. Dit. Chemical Industry : Mrs. Frida Jl. Percetakan Negara no. 23 Jakarta Pusat 10560 Phone: (021) 424 5459, 424 4755 ext. 105 Facsimile: (021) 424 3605 Email:
[email protected]
- 68 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Head of Drugs Registration : Mrs. Retno Tiasutami Jl. Percetakan Negara no. 23 Jakarta Pusat 10560 Phone: (021) 424 5459, 424 4755 ext. 110 Facsimile: (021) 4288 5404 Email:
[email protected] Head Sub. Dit. Drugs Registration : Mrs. Endang Woro Jl. Percetakan Negara no. 23 Jakarta Pusat 10560 Phone: (021) 424 5459, 424 4755 ext. 105 Facsimile: (021) 4288 5404 Email:
[email protected]
- 69 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
REFERENCES Publications ASEAN Meeting Report 1. Developments from ASEAN’s ACCSQ Pharmaceuticals Product Working Group, Manuel Zahn reports on the fourth meeting of the ACCSQ PPWG held 25–29 September 2001 in Bali, Indonesia 2. Overview Of Asia, Healthcare Markets And Regulatory Issues In The Region: Presentation At Raps, August 2001, Ames Gross, President, Pacific Bridge, Inc., August 2001 3. Update On The Asian Economies And Major Healthcare Trends, Ames Gross, Pacific Bridge, Inc. September 1998 4. Survey on Pharmaceutical industry in Indonesia, 2002, Bukhari 5. The market for pharmaceutical products and materials in Indonesia, 2004, PT Data Consult 6. P.T. Pharma Indonesia, Gunter Dufey, Priscilla Rogers, Andreas Bunanta, Michigan Business School 7. Promoting Rational Use Of Drugs at The Community Health Centers In Indonesia, Arustiyono, Department Of International Health, School Of Public Health, Boston University, September 1999 8. The Exporter’s Encyclopedia 2000/2001. New York, 2000. Dun and Bradstreet International. 9. Rochaini, Aulia. 2000. Development of Paper and packaging industry”. Retrieved on 06 Nov 2002 from http://www.tradeport.org 10. Worldwide corrugated packaging industry statistics report. International corrugated case association, 2002 11. Pacific Business and Industries. Vol.III 1996, (33): 44-49 12. Indonesia: General features of trade policy. 2002. Market Access sectoral and trade barriers database. Retrieved on 06 Nov 2002 from: http://www.mkaccdb.eu.int/mkdb/chksel.pl 13. Indonesia: Strategy for manufacturing competitiveness, Dhanani, Shafiq, UNIDO, Jakarta, 2000 14. MIMS Indonesia 15. A supply and demand survey on active ingredients/raw materials for Indonesia, Sulaeman Krishnandhi, January 2000 16. Indonesian Commercial Newsletter; November 5, 2002 17. P.T. Corinthian (CIC)
- 70 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
World Wide Web Resources 1.
US – ASEAN Business council (www.us-asean.org)
2.
GP Farmasi / Indonesian Association of Pharmaceutical Companies (www.gpfarmasi.org)
3.
Pharma – info (www.pharma-info.com)
4.
Global Sources (www.globalsources.com)
5.
Economist Intelligence Unit (www.eiu.com)
6.
Pacific Bridge, Inc (www.pacificbridgemedical.com)
7.
University of Michigan (www.umich.edu)
8.
Bank Indonesia (www.bi.go.id)
9.
Asia – Pacific Economic Cooperation (www.apecsec.org.sg)
10.
Asian Development Bank (www.adb.org)
11.
Australian Trade Commission –(www.austrade.org.au)
12.
U.S Department of Commerce – National Trade Data Bank – (www.tradeport.org)
13.
The Jakarta Post (www.thejakartapost.com)
14.
Asia Times Online (www.atimes.com)
- 71 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
- 72 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia ANNEX COMPANY/PRODUCT PROFILE FORMS
- 73 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr Hendra Purnomo, General Manager
PT DEXA MEDICA
Street - POB
EL Nusa Building #5
City - Country
Jakarta – Indonesia
Email:
[email protected]
Tel: 62-816-881485
Fax: 62-21-78846465
Year established: 1972
Number of employees: 1500
Bank Ref:
Website address of company:
Activities Exporter Wholesaler/Retailer Manufacturer/Producer Countries previously imported/exported to:
Importer
Trader
Other:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS)
I*
1.
Anaesthetics: ⌧General ansesthetics and oxygen Local anaesthetics ⌧Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) ⌧NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics ⌧Antibacterials ⌧Antifungal ⌧Antiviral ⌧Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: ⌧Plasma substitutes ⌧Plasma fractions fro specific use Cardiovascular medicines: ⌧Antianginal Antiarrhythmic ⌧Antihypertensive Used in heart failure Antithrombotic ⌧Lipid-lowering Dermatological medicines (topical) ⌧Antifungal ⌧Anti-infective ⌧Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: ⌧Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: ⌧Antacids ⌧Antiemetic ⌧Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens ⌧Insulin/other antidiabetic agents ⌧Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents ⌧Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors
⌧
Ophthalmological preparations: ⌧Anti-infective ⌧Anti-inflammatory
⌧
2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Local anesthetics
Miotics and antiglaucoma
- 74 -
Mydriatics
E*
⌧ ⌧
⌧
⌧ ⌧ ⌧ ⌧
⌧ ⌧ ⌧
⌧
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26.
⌧ ⌧
27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
Active pmarma ceutical ingredients
I* = Import, E* = Export
- 75 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title:
Drs. Fransiscus Ong
Company name
PT Pyridam Farma Tbk
Street - POB
J1. Kemandoran VIII No.16, Jakarta 12210
City - Country
Jakarta – Indonesia
Email:
[email protected]
Tel: (021) 5307551-52
Fax: (021) 5329049
Year established: 1976
Number of employees: 473 (5 / 04)
Bank Ref: BCA / NISP
Website address of company:
Activities ⌧Exporter Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer Countries previously imported/exported to:
Trader
Other:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
I*
E*
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) ⌧NSAIMs Opioid analgesics ⌧Used to treat gout ⌧DMARDs
⌧
Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics ⌧Antibacterials ⌧Antifungal ⌧Antiviral Antiprotozoal Insect repellents Antimigraine medicines: ⌧For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care
⌧ ⌧ ⌧
Antiparkinsonism medicines Medicines affecting the blood: ⌧Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure ⌧Antithrombotic ⌧Lipid-lowering Dermatological medicines (topical) Antifungal ⌧Anti-infective ⌧Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: ⌧Antiseptics ⌧Disinfectants Diuretics Gastrointestinal medicines: ⌧Antacids ⌧Antiemetic ⌧Antihaemorrhoidal ⌧Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: ⌧Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 76 -
Mydriatics
⌧ ⌧
⌧ ⌧
⌧
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26.
⌧ ⌧
27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal
⌧
⌧Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
Active Ingredients
⌧ ⌧
Tool Manufacturing Contract Manufacturing
I* = Import, E* = Export
- 77 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title:
Mr Rusdiyanto / Mr Muchcis Arifin / Director
Company name
PT Alomampa Persada / International Herbal Centre
Street - POB
Jl. Kalcmalang, Rukopori, Sentra Niaga E71, Jaktim
City - Country
Jakarta – Indonesia
Email:
[email protected]
Tel: (021) 86612471
Fax: (021) 86612472
Year established: 1995
Number of employees: 30
Bank Ref: BCA / Mandiri
Website address of company:
Activities Exporter Wholesaler/Retailer ⌧Manufacturer/Producer Countries previously imported/exported to:
Importer ⌧Trader
Other:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 78 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals
⌧
⌧Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal ⌧Medicines containing whole plant material or as raw material for the isolation of active substances or extracts
⌧ ⌧
Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material
⌧
⌧Medicinal and aromatic plants Seaweed and algae 31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
I* = Import, E* = Export
- 79 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr Ricardo A. Sopacua
PT DARYA-VARIA LABORATORIA TBK
Street - POB
JL. Melawai Raya No. 93
City - Country
Jakarta 12130, Indonesia
Email:
[email protected]
Tel: +62 21 725 8010 ext.294
Fax: +62 21 725 8009
Year established: 1976
Number of employees: 1175
Bank Ref:
Website address of company:
http://www.darya-varia.com
Activities ⌧Exporter ⌧Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer Countries previously imported/exported to:
Trader
Other:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
I*
E*
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: ⌧Antianginal ⌧Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) ⌧Antifungal ⌧Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: ⌧Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants
⌧ ⌧ ⌧
Diuretics Gastrointestinal medicines: ⌧Antacids ⌧Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea ⌧Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: ⌧Anti-infective ⌧Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 80 -
Mydriatics
⌧
⌧
⌧
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals
⌧
⌧
⌧
⌧
Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
I* = Import, E* = Export
- 81 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Dr. R. Schnapke-Zinzius, Director (Chemical Division)
PT MERCK TBK
Street - POB
Jl. TB Simatupang no. 8, PS Rebo, Jakarta 13760
City - Country
Jakarta
Email:
Tel: 62-21-8413889
Fax: 62-21-8415537
Year established:
Number of employees:
Bank Ref:
Website address of company:
Activities Exporter Wholesaler/Retailer Manufacturer/Producer Countries previously imported/exported to:
Importer
Trader
Other:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs
3. 4.
Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific
5. 6.
Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care
7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
I*
Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 82 -
Mydriatics
E*
⌧
⌧
⌧
⌧
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
⌧
⌧
27.
Vitamins and minerals
⌧
⌧
28.
Natural ingredients for pharmaceuticals
⌧ ⌧
⌧ ⌧
⌧
⌧
25. 26.
Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches ⌧Essential oils ⌧Fatty oils, fats, waxes and their derivatives Colouring agents 29.
30.
Natural ingredients for cosmetics Plant
Extracts
⌧Vitamins
Proteins
Waxes
Thickening
⌧Agents
⌧Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
I* = Import, E* = Export
- 83 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Ogin Muntahar, Export Manager
PT TEMPO SCAN PACIFIC
Street - POB
Jl. H.R. Rasuna Said Kav,11, Tromolpos: 1308 Jkt
City - Country
Jakarta 12950, Indonesia
Email:
[email protected]
Tel: 62-21-520 1858 / 5155
Fax: 62-21-520 4735
Year established: 1970
Number of employees: 600
Bank Ref: HSBC
Website address of company:
Activities Exporter Wholesaler/Retailer Manufacturer/Producer Countries previously imported/exported to:
Importer
Trader
Other:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) ⌧NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics ⌧Antibacterials Antifungal ⌧Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: ⌧Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) ⌧Antifungal Anti-infective ⌧Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives ⌧Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 84 -
Mydriatics
I*
E*
⌧ ⌧
⌧ ⌧
⌧
⌧
⌧
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26.
⌧
27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
We export the finished products but the raw materials, all imported.
I* = Import, E* = Export
- 85 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr Peter Sutandar, Deputy President Director Mr Joelianto – Mr Adi Suberman
PT PRATAPA NIRMALA - FAHRENHEIT
Street - POB
Jln Raden Saleh No. 4
City - Country
Jakarta 10430, Indonesia
Email:
[email protected] [email protected]
Tel: 62-21-390 3093
Fax: 62-21-390 3090
Year established: 1988
Number of employees: 600
Bank Ref: Bank Mandiri – Bank Central Asia
Website address of company:
Activities Exporter Wholesaler/Retailer Manufacturer/Producer Countries previously imported/exported to:
Importer
Trader
Other:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
I*
E*
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics ⌧Antibacterials ⌧Antifungal ⌧Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: ⌧Antianaemia medicines ⌧Medicines affecting coagulation Blood products and plasma substitutes: ⌧Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: ⌧Antianginal ⌧Antiarrhythmic ⌧Antihypertensive ⌧Used in heart failure ⌧Antithrombotic ⌧Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective ⌧Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: ⌧Antacids ⌧Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic ⌧Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens ⌧Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: ⌧Anti-infective ⌧Anti-inflammatory
⌧Local anesthetics
⌧Miotics and antiglaucoma
- 86 -
⌧Mydriatics
⌧
⌧ ⌧ ⌧ ⌧
⌧
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders ⌧Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral ⌧Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
I* = Import, E* = Export
- 87 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mulyana, Product Manager
PT ENSEVAL PUTERA MEGATRADING TBK
Street - POB
Jl Polo Lentut 10, Kawasan Industry Pulogadung
City - Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-46822422
Fax: 62-21-460-9039
Year established: 1973
Number of employees: 3819
Bank Ref: Lippo Bank
Website address of company:
www.enseval.com
Activities Exporter Wholesaler/Retailer Manufacturer/Producer ⌧Importer Countries previously imported/exported to:
Trader
⌧Other: Trader & Distributor
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS)
I*
1.
⌧
2.
Anaesthetics: ⌧General ansesthetics and oxygen ⌧Local anaesthetics ⌧Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs
3. 4.
Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific
5. 6.
Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics ⌧Antibacterials ⌧Antifungal ⌧Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care
7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: ⌧Antianginal Antiarrhythmic ⌧Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) ⌧Antifungal Anti-infective ⌧Anti-inflammatory/antipruritic Astringent ⌧Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: ⌧Antiseptics ⌧Disinfectants ⌧Diuretics Gastrointestinal medicines: ⌧Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: ⌧Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 88 -
Mydriatics
⌧
⌧
⌧ ⌧
⌧ ⌧ ⌧
⌧
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26.
⌧
27.
⌧Vitamins and minerals
28.
Natural ingredients for pharmaceuticals
⌧
Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents 29.
Natural ingredients for cosmetics Plant
⌧Extracts
⌧Thickening Agents 30.
⌧Vitamins
⌧Proteins
⌧Waxes
Other additives
⌧Perfumery oils
Preservatives
⌧Oils
⌧ ⌧
Raw plant material ⌧Medicinal and aromatic plants ⌧Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts
⌧
Ephedrine and ⌧quinine 32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil ⌧Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil ⌧Animal or vegetable fats and oils and their fractions ⌧Waxes ⌧Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
⌧Essential oils and oleoresins
35.
Biotech
⌧ ⌧ ⌧ ⌧ ⌧
I* = Import, E* = Export
- 89 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title:
Mr Lim Susanto, Assistant Director
Company name
PT Dankos Laboratories, Tbk
Street - POB
21 Rawa Gatel Sldk IIIs Kav 37-38, Kawasan Industri Pulogadung
City - Country
Jakarta, Indonesia
Email:
Tel: 62-21-4682 2580
Fax:
Year established: 1966
Number of employees: 800
Bank Ref:
Website address of company:
Activities
⌧Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer Countries previously imported/exported to:
Trader
Other:
IMPORT: ASIA / EUROPE EXPORT: ASIA / AFRICA
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to treat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 90 -
Mydriatics
I*
E*
⌧
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26.
⌧ ⌧
27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Raw materials and excipients
I* = Import, E* = Export
- 91 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title:
Mr Hary Seogiharta, International Business Development Manager
PT INTERBAT
Company name Street - POB
Jl. Cempaka Putih Barat 26 No. 28
City - Country
Jakarta 10520, Indonesia
Email:
[email protected]
Tel: 62-21-424 6217
Fax: 62-21-420 7218
Year established: 1948
Number of employees: 800
Bank Ref: BCA
Website address of company:
Activities
⌧Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer Countries previously imported/exported to:
Trader
Other:
IMPORT: ITALY, SPAIN, SWITZERLAND
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
⌧Opioid analgesics
I*
E*
⌧
Used to treat gout DMARDs
Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics ⌧Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic ⌧Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 92 -
Mydriatics
⌧
⌧
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
36. Ingredients: Thiamphenicol powder, Amoxicillin powder and Compact, Omeprazole Pellet 8.5%, Ciprofloxacin, Ketoconazole
⌧
I* = Import, E* = Export
- 93 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title:
Mr Djoko Sujono, Director
Company name
PT Kalbe Farma
Street - POB
Jl. M.H. Thavrin, Block A3/1, Kawasan Industry Delta Silicon, Lippo Cikarang
City - Country
Bekasi 17550, Indonesia
Email:
[email protected]
Tel: 62-21-8990 7337
Fax: 62-21-8990 7360
Year established: 1966
Number of employees: 1300
Bank Ref:
Website address of company:
Activities
⌧Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer Countries previously imported/exported to:
Trader
Other:
IMPORT: CHINA, USA, EUROPE, JAPAN EXPORT: ASIA (MYANMAR, VIETNAM, HONG KONG, SRI LANKA, IRAQ, MONGOLIA); AFRICA (NIGERIA, ZIMBABWE, SOUTH AFRICA)
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs)
⌧NSAIMs
Opioid analgesics
Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific
5. 6.
Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care
8. 9. 10. 11. 12. 13. 14. 15. 16. 17.
Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines:
⌧Antacids 18. 19. 20. 21.
Antiemetic
E*
⌧
Used to treat gout DMARDs
3. 4.
7.
I*
⌧
⌧
⌧ Antihaemorrhoidal
Anti-inflammatory
Antispasmodic Laxatives
Used in diarrhea ⌧Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 94 -
Mydriatics
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26.
⌧ ⌧
27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
36. Ingredients required for import Amoxycillin, Paracetamol, Attapulgite Coll, Hydrotalcite, Magnesium Hydroxide, Vit. C, Coffein, Pharmaceutical Packaging Material (PVC Foil)
⌧
I* = Import, E* = Export
- 95 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Gunawan Pranoto, President Director, Merzyl Ricai, Business Development Manager
PT INDOFARMA
Street - POB
Jl. Indofarma, No. 1 Cobitung
City - Country
Bekasi 17520 – West Java, Indonesia
Email:
[email protected]
Tel: 62-21-8832 3975
Fax: 62-21-8832 3973
Year established: 1918
Number of employees: 1800
Bank Ref: Bank Mandiri
Website address of company:
www.indofarma.co.id
Activities
⌧Exporter ⌧Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to: IMPORT: DENMARK, USA, KOREA, JAPAN, ITALY EXPORT: SINGAPORE, VIETNAM, RUSSIA, MYANMAR, SUDAN, NIGERIA, POLAND, IRAQ
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 96 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
Generic medicines, Herbal medicines, Over-the-counter medicines, Medical devices, Pharmaceutical machinery, Food supplement
⌧ ⌧
Licensed medicines, Food supplements, Herbal medicines
I* = Import, E* = Export
- 97 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Soediono, Director
PT ANUGERAH LESTARI
Street - POB
Jl. Pulo Letut Kav. II/E-4
City - Country
Jakarta Timur 13920, Indonesia
Email:
[email protected]
Tel: 62-21-460 4705/8820/5766
Fax: 62-21-460 9342
Year established:
Number of employees:
Bank Ref:
Website address of company:
Activities Exporter ⌧Wholesaler/Retailer Manufacturer/Producer Countries previously imported/exported to:
Importer
Trader
Other:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 98 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
BRANCHES: 25 cities and LOCAL SALES: Rp 580 billion (US$ 63.04 million)
Principals: Carlo Erba Farmitalia Combined Pharmaceutical Ind Glaxo Ind Sandoz Biochemi Farma Ind Schering Plough Ind Nutricia Ind Sejahtera Aneka Food Tatarasa Industri 3 M Indonesia Abbot Diagnostics Korea Green Cross Beaufor Ipsen Int
New Interbat Septindo Surgica Gondowangi Sariaji Perusahaan Jamu Air Mancur Dinakos Arumpratama Rohto Laboratories Ind Reckitt & Colman Ind Otsuka Ind Novartis Biocheme Heinrich Mack Nachf Novartis Nutrition Philippines Inc Smithkline Beecham Combiphar I* = Import, E* = Export
- 99 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mrs. Angela Trismotro, Director
PT DOS NI ROHA
Street - POB
Jl. M.T. Haryono Kav. 10, Gedung MUGI Griya lt.6 & 7
City - Country
Jakarta Selatan, Indonesia
Email:
Tel: 62-21-830 8494/5
Fax: 62-21-830-8493
Year established:
Number of employees:
Bank Ref:
Website address of company:
Activities Exporter ⌧Wholesaler/Retailer
Manufacturer/Producer
Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 100 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
BRANCHES: 24 cities and LOCAL SALES: Rp 310 billion (US$ 33.69 million) PRINCIPAL: CIBAGEIGY PHARMA IND
I* = Import, E* = Export
- 101 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Bistok Hutagalung, Director
PT KEBAYORAN PHARMA
Street - POB
Jl. Garuda No. 79
City - Country
Jakarta – Pusat, Indonesia
Email:
Tel: 62-21-420 7042/7032/7034
Fax: 62-21-424 3778, 428-0307
Year established:
Number of employees:
Bank Ref:
Website address of company:
Activities Exporter ⌧Wholesaler/Retailer Manufacturer/Producer Countries previously imported/exported to:
Importer
Trader
Other:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs
3. 4.
Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific
5. 6.
Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care
7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 102 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
BRANCHES: 21 cities and LOCAL SALES: Rp 290 billion (US$ 31.52 million)
I* = Import, E* = Export
- 103 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Roberto Libarnes, Marketing Director
PT WIGO-HOSLAB
Street - POB
Jl. Melawai Raya No. 93, Graha Darva-Varia, Lt. 2-3D
City - Country
Jakarta Selatan 12130, Indonesia
Email: Ricardo.sopacua@darya_varia.com
Tel: 62-21-725 8010
Fax: 62-21-725 8011/8001
Year established:
Number of employees:
Bank Ref:
Website address of company:
Activities Exporter ⌧Wholesaler/Retailer
Manufacturer/Producer
Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 104 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
BRANCHES: 9 cities and LOCAL SALES: Rp 246 billion (US$ 26.73 million) Principals:
Darya Varia Laboratories Dupa Pharmaceutical Kensore Ind
I* = Import, E* = Export
- 105 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr Budi Setia, Director
PT MENSA BINA SUKSES
Street - POB
Jl. Pulo Kambing II No. 26 , Mensa Bina Sukses, Kawasan Industri Pulo Gadung
City - Country
Jakarta, Indonesia
Email:
Tel: 62-21-460 1950,461 1778
Fax: 62-21-461 3577
Year established:
Number of employees:
Bank Ref:
Website address of company:
Activities Exporter ⌧Wholesaler/Retailer
Manufacturer/Producer
Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 106 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
BRANCHES: 14 cities and LOCAL SALES: Rp 225 billion (US$ 24.40 million)
Principals: Mensa Prima Dumex Alpharma Ind Daiici Pharmaceutical Ltd Terumo Corporation Dede Behring Jerman Vital Scientific, Netherland
Otto Pharmaceutical Industries Pertiwi Agung Hoechst Marion Roussel Ind Lynea Primisma Rama Putra Mandiri Andini Sarana I* = Import, E* = Export
- 107 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr Ronni Widjaja, Director
PT. MILLENIUM PHARMACON INTERNATIONAL TBK
Street - POB
Jl. Metro Pondok Indah Kav. II BA No. 2, Menara Citybank 7th Floor
City - Country
Jakarta 12310, Indonesia
Email:
Tel: 62-21-766 2810/16
Fax: 62-21-766 2817
Year established:
Number of employees:
Bank Ref:
Website address of company:
Activities Exporter ⌧Wholesaler/Retailer
Manufacturer/Producer
Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 108 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
BRANCHES: 22 cities and LOCAL SALES: Rp 329 billion (US$ 35.76 million)
Principals: Merck Indonesia, PT Tbk Organon Indonesia, PT Tanae-Abadi, PT Guardian Pharmatama, PT Bernofarm, PT Meiji Indonesia, PT Meprofarm, PT Tripleace Corporation Lapi Laboratories Seven Seas I.T.B.S Corporation
CSL Sanhelios P&G Tiger Mustika Ratu Atima International Inc Triarc Beverage Group Total Image Eisai Indonesia, PT Kima Farma (Persero), PT I* = Import, E* = Export
- 109 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr Cihangir Kosu, President Director
PT. ABBOTT INDONESIA
Street - POB
Menara Jamsostek, 2nd-3rd floor, Jl. Gatot Subroto kav. 38
City - Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-52961529
Fax: 62-21-52961530
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.abbott.com
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 110 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Quelicin, Ethrane
I* = Import, E* = Export
- 111 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Drs. Widya Kartasantoso, Director
PT. AFIAT PHARMACEUTICAL INDUSTRIES
Street - POB
Jl. Leuwigajah No. 138 Cimidi Rt 06/04, Kel Cigugur Tengah – Kec Cimahi Tengah, Bandung 40522, West Java
City - Country
Bandung, Indonesia
Email:
[email protected]
Tel: 62-22-6613339/40
Fax: 62-22-6613343
Year established:
Number of employees:
Bank Ref:
Website address of company:
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 112 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: All active ingredients and raw materials
I* = Import, E* = Export
- 113 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Richard Husada, President Director; Mr Steven Tanuwidjaja, Fin. Director
PT. ALPHARMA
Street - POB
Jl. Raya Jakarta Bogor Km. 28, East Jakarta 13710
City - Country
Jakarta, Indonesia
Email:
[email protected] o
Tel: 62-21-8710311
Fax: 62-21-8710044-8711382
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.accessiblemedicine.com
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 114 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: All active ingredients and raw materials
I* = Import, E* = Export
- 115 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Paul R. Latohem, President Director
PT. APEX PHARMA INDONESIA
Street - POB
Menara Batavia, 12th Floor, Jl. K.H. Mas Mansyur Kav 126, Jakarta 10220
City - Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-5746695
Fax: 62-21-5724515
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.apex-pharma.co.id
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 116 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: All active ingredients and raw materials
I* = Import, E* = Export
- 117 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Hanindijo Suja Seputra, Director
PT. ARMOXINDO FARMA
Street - POB
Jl. Arjuna No. 2 – Tanjung Duren, Jakarta 11470
City - Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-5600367-68
Fax: 62-21-5600274
Year established:
Number of employees:
Bank Ref:
Website address of company:
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 118 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: All active ingredients and raw materials
I* = Import, E* = Export
- 119 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Christian Julian Hill, Director
PT. ASTRAZENECA PHARMACEUTICAL
Street - POB
12th Floor, Deutsche Bank Building, Jl. Imam Bonjol No. 80, Jakarta 10310
City - Country
Jakarta, Indonesia
Email:
[email protected] om
Tel: 62-21-39831300
Fax: 62-21-39831301/02
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.astrazeneca.com
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 120 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: All active ingredients and raw materials
I* = Import, E* = Export
- 121 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title:
Mr. Ho Mayon Madjrouh, President Director
Company name
PT. AVENTIS PHARMA (HOECHST MARION ROUSSEL-RHONE POULENC RORER)
Street - POB
HMR Complex Pulo Mas, Jl. Jendr A Yani, Jakarta 13210
City - Country
Jakarta, Indonesia
Email:
[email protected] /
[email protected]
Tel: 62-21-4892208 / 47899867
Fax: 62-21-4751035
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.aventis.co.id
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 122 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Antigen HB1, Paracetamol, Amoxicillin
I* = Import, E* = Export
- 123 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Galatia Chandra
PT. AVENTIS PASTEUR INDONESIA
Street - POB
HMR Complex Pulo Mas, Jl. Jendr A Yani, Jakarta 13210
City – Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-47899767
Fax: 62-21-47862018
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.pasteur.or.id
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 124 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Raw materials and active ingredients
I* = Import, E* = Export
- 125 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Hans Joseph Schill, President Director; Mr Danudirdjo Ashari, Director
PT. BAYER INDONESIA
Street - POB
14th -16th Floor, Mid Plaza, Jl. Jend. Sudirman Kav 10-11, Jakarta 10220
City – Country
Jakarta, Indonesia
Email: helliyantin.djhohan.hd@bayer. ag.de
Tel: 62-21-5703661
Fax: 62-21-5703660
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.bayer.co.id
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 126 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Adalat granulate, Heparinoids, Nimotop
I* = Import, E* = Export
- 127 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Ms Devi Muftiano, Marketing Manager
PT. BEAUFOUR IPSEN INT’L
Street - POB
Wisma BSG, 8th Floor, Jl. Abdul Muis no. 40, Jakarta
City – Country
Jakarta, Indonesia
Email:
Tel: 62-21-34833360
Fax: 62-21-34833155
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.gibolan.com
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 128 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Pharmaceutical Raw Materials
I* = Import, E* = Export
- 129 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Jurgen Rohflshagen, Preseident Director; Mr. Dian P. Tamzil, Vice President Director
PT. BEIERSDORF INDONESIA
Street - POB
Gedung Bina Mulia I, 3rd floor, Jl HR Rasuna Said Kav. 11, Jakarta 13230
City – Country
Jakarta, Indonesia
Email:
[email protected] ,
[email protected]
Tel: 62-21-5201971
Fax: 62-21-5207406
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.biersdorf.com
Activities
Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 130 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Pharmaceutical Raw Materials
I* = Import, E* = Export
- 131 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Widodo Sarwono, President Director
PT. BERNOFARM
Street - POB
Jl. Kaji No. 54, Jakarta 10130
City – Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-6331431
Fax: 62-21-6331430
Year established:
Number of employees:
Bank Ref:
Website address of company:
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 132 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Pharmaceutical Raw Materials
I* = Import, E* = Export
- 133 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Wing Wiryanto, President Director; Mr. Kiman Toksana
PT. BINTANG KUPU-KUPU
Street - POB
Jl. Pluit Raya No. 132 Y, North Jakarta 14440
City – Country
Jakarta, Indonesia
Email:
Tel: 62-21-6682058/59
Fax: 62-21-6618780
Year established:
Number of employees:
Bank Ref:
Website address of company:
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 134 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Pharmaceutical Raw Materials
I* = Import, E* = Export
- 135 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Yoesef Angkasa, President Director; Mr Hilman Lukoto, Director
PT. BINTANG TOEDJOE
Street - POB
Jl. A Yani no. 2, Pulomas, East Jakarta
City – Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-4757777
Fax: 62-21-4701672
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.bintang7.com / www.extrajoss.com
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 136 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Acetosal, Paracetamol
I* = Import, E* = Export
- 137 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Drs. Marzuki Abdullah, President Director; Drs. Kurnia Kusuma Negara, Director
PT. BIO FARMA (PERSERO)
Street - POB
Jl. Pasterur No. 28 Rt. 09/08, Kel Pasteur – Kec Sukajadi, bandung 40161, West Java
City – Country
Bandung, Indonesia
Email:
[email protected]
Tel: 62-22-2033755
Fax: 62-22-2041306
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.biofarma.co.id
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 138 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Rimevax diluent, heaccine-8, Rouvax, Tetanus Antitoxin, Hepa-B
I* = Import, E* = Export
- 139 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mrs. Lia Lidyawaty, Manager
PT. BIOMED PRODUCTS
Street - POB
Comp. Lokasari Blok A 6, Jl. Mangga Besar Raya, Jakarta 11170
City – Country
Jakarta, Indonesia
Email:
Tel: 62-21-6252387
Fax: 62-21-6267416
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.appeton.com
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 140 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Pharmaceutical Raw Materials
I* = Import, E* = Export
- 141 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Gunadi Luski, Director
PT. BISON HUTAMA
Street - POB
Jl. Pancoran No. 11, Glodok, Jakarta 11120
City – Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-6296866
Fax: 62-21-6599078
Year established:
Number of employees:
Bank Ref:
Website address of company:
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 142 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Pharmaceutical Raw Materials
I* = Import, E* = Export
- 143 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Drs. Gunawan Pranoto, President Director; Mr. M Syamsul Arifin, Finance Director
PT. KIMIA FARMA TBK
Street - POB
Jl. Budi Utomo No. 1, Kel Pasar Baru, Kec Sawah Besar, Central Jakarta
City – Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-3849251
Fax: 62-21-3441418
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.kimiafarma.co.id
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 144 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
36. Ingredients: Vincrystine injection, Lamprene, Cefmetazon, Alexan 40, Dentanyl Injection
⌧ I* = Import, E* = Export
- 145 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. E.J. Bos, President Director
PT. ORGANON INDONESIA
Street - POB
Jl. Raya Veteran – Bintaro, Kebayoran Lama, South Jakarta 12330
City – Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-7359988/7363739
Fax: 62-21-7363736
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.organon.co.id
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 146 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Carbazochrom Oral G
I* = Import, E* = Export
- 147 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Ben Setiadi
PT. PHAROS TBK
Street - POB
Jl Lomo 40, Permata Hijau Rt 08/10, Senayan, Grogol, Kebayoran Lama, Jakarta 12950
City – Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-7200981
Fax: 62-21-7260788
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.phapros.co.id
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 148 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
36. Ingredients: Ampicillin, Amoxcycillin, Tegracycline, Antalgin, Mefenemik Acid, Liver extract, Dessicated Liver Powder
⌧ I* = Import, E* = Export
- 149 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Andre Lembong, President Director
PT. PHAROS INDONESIA
Street - POB
Jl. Lomo 40, Permata Hijau Rt 08/10, Senayan, Grogol Selatan, Kec Kebayoran Lama, Jakarta 12950
City – Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-7244415
Fax: 62-21-7260788
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.pharos.co.id
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
I*
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 150 -
Mydriatics
⌧
⌧
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
36. Ingredients: Antineoplastic Drigs, Antidiabetic Drugs, Antibiotic Drugs, Hormone products, Engerix-b, Tagament, Tracrium
⌧ ⌧ I* = Import, E* = Export
- 151 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Prof. Dr. Midian Sirait, President Director
PT. PHYTO KEMO AGUNG FARMA
Street - POB
Jl. Mesjid no. 90 Kel. Susukan, Kec. Pasar Rebo, East Jakarta 13750
City – Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-8400263
Fax: 62-21-8400533
Year established:
Number of employees:
Bank Ref:
Website address of company:
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
I*
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care
⌧
Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 152 -
Mydriatics
⌧
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧ ⌧
36. Ingredients: Framidex, Colicurse Gentadexa
I* = Import, E* = Export
- 153 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Manuel P. Engwa, President Director
PT. PRAFA (PRADJA PHARIN)
Street - POB
Graha Darya Varia, Jl. Melawai Raya No. 93, Kel. Kramat Pela – Kec Kebayoran Baru, South Jakarta 12130
City – Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-7258010
Fax: 62-21-7258011
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.darya-varia.com
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
I*
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 154 -
Mydriatics
⌧
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
36. Ingredients: Hyperhep, Hypertet, Konyne, Gamimune N, Hyperrab, Profasi, Gamastan
⌧ I* = Import, E* = Export
- 155 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Dieter Garbade, President Director
PT. ROCHE INDONESIA
Street - POB
Gd. Artha Graha, 21st –22nd Floor, Jl. Jend. Sudirman Kav. 52-53, Jakarta 12190
City – Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-51400081/82
Fax: 62-21-51400038
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.roche.com
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
I*
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 156 -
Mydriatics
⌧
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Roveron, A3mu, Hyleran, Welliferon 3mu
I* = Import, E* = Export
- 157 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Drs. Jahja Santosa, President Director
PT. SANBE FARMA
Street - POB
Jl. Taman Sari No. 10, Bandung 40116, West Java
City – Country
Bandung, Indonesia
Email:
[email protected] ,
[email protected]
Tel: 62-22-4207725/4209225
Fax: 62-21-4238476
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.sanbe-farma.com
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
I*
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 158 -
Mydriatics
⌧
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26.
⌧
27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
36. Ingredients: Amoxycilin, ampicillin, Antalgin, Cefradroxyle, Cefaraxime, Ketoconazole, Kolidon K 25, Microcel M102, Paracetamol, Rifampicin, Vitamins
⌧ I* = Import, E* = Export
- 159 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. Hans Peter Hausner, President Director
PT. SCHERING INDONESIA
Street - POB
Jl. TB Simaputang – Pasar Rebo, East Jakarta 13760
City – Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-8400121/4
Fax: 62-21-8401396
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.schering.de
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines
20.
Muscle relaxants (peripherally acting) and cholinesterase inhibitors
21.
Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 160 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Catapres Triuration, Spriopent Trituration
I* = Import, E* = Export
- 161 -
Supply and demand survey on pharmaceuticals and natural products – Indonesia
Name and Title: Company name
Mr. James Latimen Collyer, Director
PT. SCHERING PLOUGH INDONESIA
Street - POB
Wisma Bank Dharmala Lt. 10, Jl. Jend Sudirman Kav. 28, Jakarta 12910
City – Country
Jakarta, Indonesia
Email:
[email protected]
Tel: 62-21-5225452
Fax: 62-21-5225446
Year established:
Number of employees:
Bank Ref:
Website address of company:
www.spcorp.com
Activities Exporter
Wholesaler/Retailer ⌧Manufacturer/Producer ⌧Importer
Trader
Other:
Countries previously imported/exported to:
DESCRIPTION (PLEASE GIVE GENERIC NAMES AND SPECIFY IF THE PRODUCT IS INDIGENOUS) 1. 2.
3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21.
Anaesthetics: General ansesthetics and oxygen Local anaesthetics Preoperative medication and sedation Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to threat gout and disease modifying agents in rheumatoid disorders (DMARDs) NSAIMs Opioid analgesics Used to treat gout DMARDs Antiallergics and medicines used in anaphylaxis Antidotes and other substances used in poisoning: Non-specific Specific Anticonvulstants/antiepileptics: Anti-infective medicines: Anthelminthics Antibacterials Antifungal Antiviral Antiprotozoal Insect repellents Antimigraine medicines: For treatment of acute attack For prophylaxis Antineoplastic, immunosuppressives and medicines used in palliative care: Immunosuppressive Cytotoxic medicines Hormones and antihormones Medicines used in palliative care Antiparkinsonism medicines Medicines affecting the blood: Antianaemia medicines Medicines affecting coagulation Blood products and plasma substitutes: Plasma substitutes Plasma fractions fro specific use Cardiovascular medicines: Antianginal Antiarrhythmic Antihypertensive Used in heart failure Antithrombotic Lipid-lowering Dermatological medicines (topical) Antifungal Anti-infective Anti-inflammatory/antipruritic Astringent Skin differentiation/proliferation Scabicides/pediculicides Ultraviolet Diagnostic agents: Ophthalmic Radio contrast media Disinfectants and antiseptics: Antiseptics Disinfectants Diuretics Gastrointestinal medicines: Antacids Antiemetic Antihaemorrhoidal Anti-inflammatory Antispasmodic Laxatives Used in diarrhea Antidiarrhoeal (symptomatic) Hormones, other endocrine medicines and contraceptives: Adrenal/synthetic substitutes Androgens Contraceptives Estrogens Insulin/other antidiabetic agents Ovulation inducers Progestogens Thyroid hormones/antithyroid medicines Immunologicals: Diagnostic agents Sera and immunoglobulins Vaccines Muscle relaxants (peripherally acting) and cholinesterase inhibitors Ophthalmological preparations: Anti-infective Anti-inflammatory
Local anesthetics
Miotics and antiglaucoma
- 162 -
Mydriatics
I*
E*
Supply and demand survey on pharmaceuticals and natural products – Indonesia
22.
Oxytocics and antioxytocics: Oxytocics Antioxytocics
23. 24.
Peritoneal dialysis solution Psychotherapeutic medicines: Psychotic disorders Mood disorders Generalized anxiety and sleep disorders Obsessive compulsive disorders Medicines acting on the respiratory tract Solutions correcting water, electrolyte and acid-base disturbances: Oral Parenteral Miscellaneous
25. 26. 27.
Vitamins and minerals
28.
Natural ingredients for pharmaceuticals Crude raw materials such as roots, rhizomes, leaves, fruits, seeds and (root) barks to be used in herbal Medicines containing whole plant material or as raw material for the isolation of active substances or extracts Saps and extracts, tinctures, balsams, lacs, gums, resins and starches Essential oils Fatty oils, fats, waxes and their derivatives Colouring agents
29.
30.
Natural ingredients for cosmetics Plant
Extracts
Vitamins
Proteins
Waxes
Thickening
Agents
Other additives
Perfumery oils
Preservatives
Oils
Raw plant material Medicinal and aromatic plants Seaweed and algae
31.
Vegetable saps and extracts Lacs, natural gums, resins, gum-resins and balsams Other vegetable saps and extracts Ephedrine and quinine
32.
Vegetables (and animal) derived oils, fats and waxes Peanut oil & its fractions Coconut, palm kernel or babassu oil Fixed vegetable fats and oils and their fractions, such as jojoba oil, castor oil, tung oil and sesame oil Animal or vegetable fats and oils and their fractions Waxes Cocoa butter, fat and oil
33.
Colouring matter of vegetable or animal origin
34.
Essential oils and oleoresins
35.
Biotech
⌧
36. Ingredients: Flutamide tablet
I* = Import, E* = Export
- 163 -
